Title 21

Volume 6 CHAPTER I SUBCHAP E

Subchapter E - Animal Drugs, Feeds, And Related Products

21:6.0.1.1.1PART 500
PART 500 - GENERAL
21:6.0.1.1.1.1SUBPART A
Subpart A [Reserved]
21:6.0.1.1.1.2SUBPART B
Subpart B - Specific Administrative Rulings and Decisions
21:6.0.1.1.1.2.1.1SECTION 500.23
     500.23 Thermally processed low-acid foods packaged in hermetically sealed containers.
21:6.0.1.1.1.2.1.2SECTION 500.24
     500.24 Emergency permit control.
21:6.0.1.1.1.2.1.3SECTION 500.25
     500.25 Anthelmintic drugs for use in animals.
21:6.0.1.1.1.2.1.4SECTION 500.26
     500.26 Timed-release dosage form drugs.
21:6.0.1.1.1.2.1.5SECTION 500.27
     500.27 Methylene blue-containing drugs for use in animals.
21:6.0.1.1.1.2.1.6SECTION 500.29
     500.29 Gentian violet for use in animal feed.
21:6.0.1.1.1.2.1.7SECTION 500.30
     500.30 Gentian violet for animal drug use.
21:6.0.1.1.1.2.1.8SECTION 500.45
     500.45 Use of polychlorinated biphenyls (PCB's) in the production, handling, and storage of animal feed.
21:6.0.1.1.1.2.1.9SECTION 500.46
     500.46 Hexachlorophene in animal drugs.
21:6.0.1.1.1.2.1.10SECTION 500.50
     500.50 Propylene glycol in or on cat food.
21:6.0.1.1.1.3SUBPART C
Subpart C - Animal Drug Labeling Requirements
21:6.0.1.1.1.3.1.1SECTION 500.51
     500.51 Labeling of animal drugs; misbranding.
21:6.0.1.1.1.3.1.2SECTION 500.52
     500.52 Use of terms such as “tonic”, “tone”, “toner”, or “conditioner” in the labeling of preparations intended for use in or on animals.
21:6.0.1.1.1.3.1.3SECTION 500.55
     500.55 Exemption from certain drug-labeling requirements.
21:6.0.1.1.1.4SUBPART D
Subpart D - Requirements for Specific Animal Drugs
21:6.0.1.1.1.4.1.1SECTION 500.65
     500.65 Epinephrine injection 1:1,000 in 10-milliliter containers for emergency treatment of anaphylactoid shock in cattle, horses, sheep, and swine.
21:6.0.1.1.1.5SUBPART E
Subpart E - Regulation of Carcinogenic Compounds Used in Food-Producing Animals
21:6.0.1.1.1.5.1.1SECTION 500.80
     500.80 Scope of this subpart.
21:6.0.1.1.1.5.1.2SECTION 500.82
     500.82 Definitions.
21:6.0.1.1.1.5.1.3SECTION 500.84
     500.84 Conditions for approval of the sponsored compound.
21:6.0.1.1.1.5.1.4SECTION 500.86
     500.86 Marker residue and target tissue.
21:6.0.1.1.1.5.1.5SECTION 500.88
     500.88 Regulatory method.
21:6.0.1.1.1.5.1.6SECTION 500.90
     500.90 Waiver of requirements.
21:6.0.1.1.1.5.1.7SECTION 500.92
     500.92 Implementation.
21:6.0.1.1.1.6SUBPART F
Subpart F - Methods for Detection of Residues of Carcinogenic Compounds Used in Food-Producing Animals
21:6.0.1.1.1.6.1.1SECTION 500.1410
     500.1410 N-methyl-2-pyrrolidone.
21:6.0.1.1.2PART 501
PART 501 - ANIMAL FOOD LABELING
21:6.0.1.1.2.1SUBPART A
Subpart A - General Provisions
21:6.0.1.1.2.1.1.1SECTION 501.1
     501.1 Principal display panel of package form animal food.
21:6.0.1.1.2.1.1.2SECTION 501.2
     501.2 Information panel of package for animal food.
21:6.0.1.1.2.1.1.3SECTION 501.3
     501.3 Identity labeling of animal food in package form.
21:6.0.1.1.2.1.1.4SECTION 501.4
     501.4 Animal food; designation of ingredients.
21:6.0.1.1.2.1.1.5SECTION 501.5
     501.5 Animal food; name and place of business of manufacturer, packer, or distributor.
21:6.0.1.1.2.1.1.6SECTION 501.8
     501.8 Labeling of animal food with number of servings.
21:6.0.1.1.2.1.1.7SECTION 501.15
     501.15 Animal food; prominence of required statements.
21:6.0.1.1.2.1.1.8SECTION 501.17
     501.17 Animal food labeling warning statements.
21:6.0.1.1.2.1.1.9SECTION 501.18
     501.18 Misbranding of animal food.
21:6.0.1.1.2.2SUBPART B
Subpart B - Specific Animal Food Labeling Requirements
21:6.0.1.1.2.2.1.1SECTION 501.22
     501.22 Animal foods; labeling of spices, flavorings, colorings, and chemical preservatives.
21:6.0.1.1.2.3SUBPART C
Subparts C-E [Reserved]
21:6.0.1.1.2.4SUBPART F
Subpart F - Exemptions From Animal Food Labeling Requirements
21:6.0.1.1.2.4.1.1SECTION 501.100
     501.100 Animal food; exemptions from labeling.
21:6.0.1.1.2.4.1.2SECTION 501.103
     501.103 Petitions requesting exemptions from or special requirements for label declaration of ingredients.
21:6.0.1.1.2.4.1.3SECTION 501.105
     501.105 Declaration of net quantity of contents when exempt.
21:6.0.1.1.2.4.1.4SECTION 501.110
     501.110 Animal feed labeling; collective names for feed ingredients.
21:6.0.1.1.3PART 502
PART 502 - COMMON OR USUAL NAMES FOR NONSTANDARDIZED ANIMAL FOODS
21:6.0.1.1.3.0.1.1SECTION 502.5
     502.5 General principles.
21:6.0.1.1.3.0.1.2SECTION 502.19
     502.19 Petitions.
21:6.0.1.1.4PART 507
PART 507 - CURRENT GOOD MANUFACTURING PRACTICE, HAZARD ANALYSIS, AND RISK-BASED PREVENTIVE CONTROLS FOR FOOD FOR ANIMALS
21:6.0.1.1.4.1SUBPART A
Subpart A - General Provisions
21:6.0.1.1.4.1.1.1SECTION 507.1
     507.1 Applicability and status.
21:6.0.1.1.4.1.1.2SECTION 507.3
     507.3 Definitions.
21:6.0.1.1.4.1.1.3SECTION 507.4
     507.4 Qualifications of individuals who manufacture, process, pack, or hold animal food.
21:6.0.1.1.4.1.1.4SECTION 507.5
     507.5 Exemptions.
21:6.0.1.1.4.1.1.5SECTION 507.7
     507.7 Requirements that apply to a qualified facility.
21:6.0.1.1.4.1.1.6SECTION 507.10
     507.10 Applicability of subparts C and E of this part to a facility solely engaged in the storage of unexposed packaged animal food.
21:6.0.1.1.4.1.1.7SECTION 507.12
     507.12 Applicability of this part to the holding and distribution of human food by-products for use as animal food.
21:6.0.1.1.4.2SUBPART B
Subpart B - Current Good Manufacturing Practice
21:6.0.1.1.4.2.1.1SECTION 507.14
     507.14 Personnel.
21:6.0.1.1.4.2.1.2SECTION 507.17
     507.17 Plant and grounds.
21:6.0.1.1.4.2.1.3SECTION 507.19
     507.19 Sanitation.
21:6.0.1.1.4.2.1.4SECTION 507.20
     507.20 Water supply and plumbing.
21:6.0.1.1.4.2.1.5SECTION 507.22
     507.22 Equipment and utensils.
21:6.0.1.1.4.2.1.6SECTION 507.25
     507.25 Plant operations.
21:6.0.1.1.4.2.1.7SECTION 507.27
     507.27 Holding and distribution.
21:6.0.1.1.4.2.1.8SECTION 507.28
     507.28 Holding and distribution of human food by-products for use as animal food.
21:6.0.1.1.4.3SUBPART C
Subpart C - Hazard Analysis and Risk-Based Preventive Controls
21:6.0.1.1.4.3.1.1SECTION 507.31
     507.31 Food safety plan.
21:6.0.1.1.4.3.1.2SECTION 507.33
     507.33 Hazard analysis.
21:6.0.1.1.4.3.1.3SECTION 507.34
     507.34 Preventive controls.
21:6.0.1.1.4.3.1.4SECTION 507.36
     507.36 Circumstances in which the owner, operator, or agent in charge of a manufacturing/processing facility is not required to implement a preventive control.
21:6.0.1.1.4.3.1.5SECTION 507.37
     507.37 Provision of assurances required under § 507.36(a)(2), (3), and (4).
21:6.0.1.1.4.3.1.6SECTION 507.38
     507.38 Recall plan.
21:6.0.1.1.4.3.1.7SECTION 507.39
     507.39 Preventive control management components.
21:6.0.1.1.4.3.1.8SECTION 507.40
     507.40 Monitoring.
21:6.0.1.1.4.3.1.9SECTION 507.42
     507.42 Corrective actions and corrections.
21:6.0.1.1.4.3.1.10SECTION 507.45
     507.45 Verification.
21:6.0.1.1.4.3.1.11SECTION 507.47
     507.47 Validation.
21:6.0.1.1.4.3.1.12SECTION 507.49
     507.49 Verification of implementation and effectiveness.
21:6.0.1.1.4.3.1.13SECTION 507.50
     507.50 Reanalysis.
21:6.0.1.1.4.3.1.14SECTION 507.51
     507.51 Modified requirements that apply to a facility solely engaged in the storage of unexposed packaged animal food.
21:6.0.1.1.4.3.1.15SECTION 507.53
     507.53 Requirements applicable to a preventive controls qualified individual and a qualified auditor.
21:6.0.1.1.4.3.1.16SECTION 507.55
     507.55 Implementation records required for this subpart.
21:6.0.1.1.4.4SUBPART D
Subpart D - Withdrawal of a Qualified Facility Exemption
21:6.0.1.1.4.4.1.1SECTION 507.60
     507.60 Circumstances that may lead FDA to withdraw a qualified facility exemption.
21:6.0.1.1.4.4.1.2SECTION 507.62
     507.62 Issuance of an order to withdraw a qualified facility exemption.
21:6.0.1.1.4.4.1.3SECTION 507.65
     507.65 Contents of an order to withdraw a qualified facility exemption.
21:6.0.1.1.4.4.1.4SECTION 507.67
     507.67 Compliance with, or appeal of, an order to withdraw a qualified facility exemption.
21:6.0.1.1.4.4.1.5SECTION 507.69
     507.69 Procedure for submitting an appeal.
21:6.0.1.1.4.4.1.6SECTION 507.71
     507.71 Procedure for requesting an informal hearing.
21:6.0.1.1.4.4.1.7SECTION 507.73
     507.73 Requirements applicable to an informal hearing.
21:6.0.1.1.4.4.1.8SECTION 507.75
     507.75 Presiding officer for an appeal and for an informal hearing.
21:6.0.1.1.4.4.1.9SECTION 507.77
     507.77 Timeframe for issuing a decision on an appeal.
21:6.0.1.1.4.4.1.10SECTION 507.80
     507.80 Revocation of an order to withdraw a qualified facility exemption.
21:6.0.1.1.4.4.1.11SECTION 507.83
     507.83 Final agency action.
21:6.0.1.1.4.4.1.12SECTION 507.85
     507.85 Reinstatement of a qualified facility exemption that was withdrawn.
21:6.0.1.1.4.5SUBPART E
Subpart E - Supply-Chain Program
21:6.0.1.1.4.5.1.1SECTION 507.105
     507.105 Requirement to establish and implement a supply-chain program.
21:6.0.1.1.4.5.1.2SECTION 507.110
     507.110 General requirements applicable to a supply-chain program.
21:6.0.1.1.4.5.1.3SECTION 507.115
     507.115 Responsibilities of the receiving facility.
21:6.0.1.1.4.5.1.4SECTION 507.120
     507.120 Using approved suppliers.
21:6.0.1.1.4.5.1.5SECTION 507.125
     507.125 Determining appropriate supplier verification activities (including determining the frequency of conducting the activity).
21:6.0.1.1.4.5.1.6SECTION 507.130
     507.130 Conducting supplier verification activities for raw materials and other ingredients.
21:6.0.1.1.4.5.1.7SECTION 507.135
     507.135 Onsite audit.
21:6.0.1.1.4.5.1.8SECTION 507.175
     507.175 Records documenting the supply-chain program.
21:6.0.1.1.4.6SUBPART F
Subpart F - Requirements Applying to Records That Must Be Established and Maintained
21:6.0.1.1.4.6.1.1SECTION 507.200
     507.200 Records subject to the requirements of this subpart.
21:6.0.1.1.4.6.1.2SECTION 507.202
     507.202 General requirements applying to records.
21:6.0.1.1.4.6.1.3SECTION 507.206
     507.206 Additional requirements applying to the food safety plan.
21:6.0.1.1.4.6.1.4SECTION 507.208
     507.208 Requirements for record retention.
21:6.0.1.1.4.6.1.5SECTION 507.212
     507.212 Use of existing records.
21:6.0.1.1.4.6.1.6SECTION 507.215
     507.215 Special requirements applicable to a written assurance.
21:6.0.1.1.5PART 509
PART 509 - UNAVOIDABLE CONTAMINANTS IN ANIMAL FOOD AND FOOD-PACKAGING MATERIAL
21:6.0.1.1.5.1SUBPART A
Subpart A - General Provisions
21:6.0.1.1.5.1.1.1SECTION 509.3
     509.3 Definitions and interpretations.
21:6.0.1.1.5.1.1.2SECTION 509.4
     509.4 Establishment of tolerances, regulatory limits, and action levels.
21:6.0.1.1.5.1.1.3SECTION 509.5
     509.5 Petitions.
21:6.0.1.1.5.1.1.4SECTION 509.6
     509.6 Added poisonous or deleterious substances.
21:6.0.1.1.5.1.1.5SECTION 509.7
     509.7 Unavoidability.
21:6.0.1.1.5.1.1.6SECTION 509.15
     509.15 Use of polychlorinated biphenyls (PCB's) in establishments manufacturing food-packaging materials.
21:6.0.1.1.5.2SUBPART B
Subpart B - Tolerances for Unavoidable Poisonous or Deleterious Substances
21:6.0.1.1.5.2.1.1SECTION 509.30
     509.30 Temporary tolerances for polychlorinated biphenyls (PCB's).
21:6.0.1.1.5.3SUBPART C
Subpart C - Regulatory Limits for Added Poisonous or Deleterious Substances [Reserved]
21:6.0.1.1.5.4SUBPART D
Subpart D - Naturally Occurring Poisonous or Deleterious Substances [Reserved]
21:6.0.1.1.6PART 510
PART 510 - NEW ANIMAL DRUGS
21:6.0.1.1.6.1SUBPART A
Subpart A - General Provisions
21:6.0.1.1.6.1.1.1SECTION 510.3
     510.3 Definitions and interpretations.
21:6.0.1.1.6.1.1.2SECTION 510.4
     510.4 Biologics; products subject to license control.
21:6.0.1.1.6.1.1.3SECTION 510.7
     510.7 Consignees of new animal drugs for use in the manufacture of animal feed.
21:6.0.1.1.6.1.1.4SECTION 510.95
     510.95 [Reserved]
21:6.0.1.1.6.2SUBPART B
Subpart B - Specific Administrative Rulings and Decisions
21:6.0.1.1.6.2.1.1SECTION 510.105
     510.105 Labeling of drugs for use in milk-producing animals.
21:6.0.1.1.6.2.1.2SECTION 510.106
     510.106 Labeling of antibiotic and antibiotic-containing drugs intended for use in milk-producing animals.
21:6.0.1.1.6.2.1.3SECTION 510.110
     510.110 Antibiotics used in food-producing animals.
21:6.0.1.1.6.2.1.4SECTION 510.112
     510.112 Antibiotics used in veterinary medicine and for nonmedical purposes; required data.
21:6.0.1.1.6.3SUBPART C
Subpart C [Reserved]
21:6.0.1.1.6.4SUBPART D
Subpart D - Records and Reports
21:6.0.1.1.6.4.1.1SECTION 510.301
     510.301 Records and reports concerning experience with animal feeds bearing or containing new animal drugs for which an approved medicated feed mill license application is in effect.
21:6.0.1.1.6.4.1.2SECTION 510.305
     510.305 Maintenance of copies of approved medicated feed mill licenses to manufacture animal feed bearing or containing new animal drugs.
21:6.0.1.1.6.5SUBPART E
Subpart E - Requirements for Specific New Animal Drugs
21:6.0.1.1.6.5.1.1SECTION 510.410
     510.410 Corticosteroids for oral, injectable, and ophthalmic use in animals; warnings and labeling requirements.
21:6.0.1.1.6.5.1.2SECTION 510.440
     510.440 Injectable iron preparations.
21:6.0.1.1.6.5.1.3SECTION 510.455
     510.455 Requirements for free-choice medicated feeds.
21:6.0.1.1.6.6SUBPART F
Subpart F [Reserved]
21:6.0.1.1.6.7SUBPART G
Subpart G - Sponsors of Approved Applications
21:6.0.1.1.6.7.1.1SECTION 510.600
     510.600 Names, addresses, and drug labeler codes of sponsors of approved applications.
21:6.0.1.1.7PART 511
PART 511 - NEW ANIMAL DRUGS FOR INVESTIGATIONAL USE
21:6.0.1.1.7.0.1.1SECTION 511.1
     511.1 New animal drugs for investigational use exempt from section 512(a) of the Federal Food, Drug, and Cosmetic Act.
21:6.0.1.1.7.0.1.2SECTION 511.3
     511.3 Definitions.
21:6.0.1.1.8PART 514
PART 514 - NEW ANIMAL DRUG APPLICATIONS
21:6.0.1.1.8.1SUBPART A
Subpart A - General Provisions
21:6.0.1.1.8.1.1.1SECTION 514.1
     514.1 Applications.
21:6.0.1.1.8.1.1.2SECTION 514.3
     514.3 Definitions.
21:6.0.1.1.8.1.1.3SECTION 514.4
     514.4 Substantial evidence.
21:6.0.1.1.8.1.1.4SECTION 514.5
     514.5 Presubmission conferences.
21:6.0.1.1.8.1.1.5SECTION 514.6
     514.6 Amended applications.
21:6.0.1.1.8.1.1.6SECTION 514.7
     514.7 Withdrawal of applications without prejudice.
21:6.0.1.1.8.1.1.7SECTION 514.8
     514.8 Supplements and other changes to an approved application.
21:6.0.1.1.8.1.1.8SECTION 514.11
     514.11 Confidentiality of data and information in a new animal drug application file.
21:6.0.1.1.8.1.1.9SECTION 514.12
     514.12 Confidentiality of data and information in an investigational new animal drug notice.
21:6.0.1.1.8.1.1.10SECTION 514.15
     514.15 Untrue statements in applications.
21:6.0.1.1.8.2SUBPART B
Subpart B - Administrative Actions on Applications
21:6.0.1.1.8.2.1.1SECTION 514.80
     514.80 Records and reports concerning experience with approved new animal drugs.
21:6.0.1.1.8.2.1.2SECTION 514.87
     514.87 Annual reports for antimicrobial animal drug sales and distribution.
21:6.0.1.1.8.2.1.3SECTION 514.100
     514.100 Evaluation and comment on applications.
21:6.0.1.1.8.2.1.4SECTION 514.105
     514.105 Approval of applications.
21:6.0.1.1.8.2.1.5SECTION 514.106
     514.106 Approval of supplemental applications.
21:6.0.1.1.8.2.1.6SECTION 514.110
     514.110 Reasons for refusing to file applications.
21:6.0.1.1.8.2.1.7SECTION 514.111
     514.111 Refusal to approve an application.
21:6.0.1.1.8.2.1.8SECTION 514.115
     514.115 Withdrawal of approval of applications.
21:6.0.1.1.8.2.1.9SECTION 514.116
     514.116 Notice of withdrawal of approval of application.
21:6.0.1.1.8.2.1.10SECTION 514.117
     514.117 Adequate and well-controlled studies.
21:6.0.1.1.8.2.1.11SECTION 514.120
     514.120 Revocation of order refusing to approve an application or suspending or withdrawing approval of an application.
21:6.0.1.1.8.2.1.12SECTION 514.121
     514.121 Service of notices and orders.
21:6.0.1.1.8.3SUBPART C
Subpart C - Hearing Procedures
21:6.0.1.1.8.3.1.1SECTION 514.200
     514.200 Notice of opportunity for hearing; notice of participation and requests for hearing; grant or denial of hearing.
21:6.0.1.1.8.3.1.2SECTION 514.201
     514.201 Procedures for hearings.
21:6.0.1.1.8.4SUBPART D
Subparts D-E [Reserved]
21:6.0.1.1.8.5SUBPART F
Subpart F - Judicial Review
21:6.0.1.1.8.5.1.1SECTION 514.235
     514.235 Judicial review.
21:6.0.1.1.9PART 515
PART 515 - MEDICATED FEED MILL LICENSE
21:6.0.1.1.9.1SUBPART A
Subpart A - Applications
21:6.0.1.1.9.1.1.1SECTION 515.10
     515.10 Medicated feed mill license applications.
21:6.0.1.1.9.1.1.2SECTION 515.11
     515.11 Supplemental medicated feed mill license applications.
21:6.0.1.1.9.2SUBPART B
Subpart B - Administrative Actions on Licenses
21:6.0.1.1.9.2.1.1SECTION 515.20
     515.20 Approval of medicated feed mill license applications.
21:6.0.1.1.9.2.1.2SECTION 515.21
     515.21 Refusal to approve a medicated feed mill license application.
21:6.0.1.1.9.2.1.3SECTION 515.22
     515.22 Suspension and/or revocation of approval of a medicated feed mill license.
21:6.0.1.1.9.2.1.4SECTION 515.23
     515.23 Voluntary revocation of medicated feed mill license.
21:6.0.1.1.9.2.1.5SECTION 515.24
     515.24 Notice of revocation of a medicated feed mill license.
21:6.0.1.1.9.2.1.6SECTION 515.25
     515.25 Revocation of order refusing to approve a medicated feed mill license application or suspending or revoking a license.
21:6.0.1.1.9.2.1.7SECTION 515.26
     515.26 Services of notices and orders.
21:6.0.1.1.9.3SUBPART C
Subpart C - Hearing Procedures
21:6.0.1.1.9.3.1.1SECTION 515.30
     515.30 Contents of notice of opportunity for a hearing.
21:6.0.1.1.9.3.1.2SECTION 515.31
     515.31 Procedures for hearings.
21:6.0.1.1.9.4SUBPART D
Subpart D - Judicial Review
21:6.0.1.1.9.4.1.1SECTION 515.40
     515.40 Judicial review.
21:6.0.1.1.10PART 516
PART 516 - NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES
21:6.0.1.1.10.1SUBPART A
Subpart A - General Provisions
21:6.0.1.1.10.1.1.1SECTION 516.1
     516.1 Scope.
21:6.0.1.1.10.1.1.2SECTION 516.2
     516.2 Purpose.
21:6.0.1.1.10.1.1.3SECTION 516.3
     516.3 Definitions.
21:6.0.1.1.10.2SUBPART B
Subpart B - Designation of a Minor Use or Minor Species New Animal Drug
21:6.0.1.1.10.2.1.1SECTION 516.11
     516.11 Scope of this subpart.
21:6.0.1.1.10.2.1.2SECTION 516.12
     516.12 Purpose.
21:6.0.1.1.10.2.1.3SECTION 516.13
     516.13 Definitions.
21:6.0.1.1.10.2.1.4SECTION 516.14
     516.14 Submission of requests for designation.
21:6.0.1.1.10.2.1.5SECTION 516.16
     516.16 Eligibility to request designation.
21:6.0.1.1.10.2.1.6SECTION 516.20
     516.20 Content and format of a request for MUMS-drug designation.
21:6.0.1.1.10.2.1.7SECTION 516.21
     516.21 Documentation of minor use status.
21:6.0.1.1.10.2.1.8SECTION 516.22
     516.22 Permanent-resident U.S. agent for foreign sponsor.
21:6.0.1.1.10.2.1.9SECTION 516.23
     516.23 Timing of requests for MUMS-drug designation.
21:6.0.1.1.10.2.1.10SECTION 516.24
     516.24 Granting MUMS-drug designation.
21:6.0.1.1.10.2.1.11SECTION 516.25
     516.25 Refusal to grant MUMS-drug designation.
21:6.0.1.1.10.2.1.12SECTION 516.26
     516.26 Amendment to MUMS-drug designation.
21:6.0.1.1.10.2.1.13SECTION 516.27
     516.27 Change in sponsorship.
21:6.0.1.1.10.2.1.14SECTION 516.28
     516.28 Publication of MUMS-drug designations.
21:6.0.1.1.10.2.1.15SECTION 516.29
     516.29 Termination of MUMS-drug designation.
21:6.0.1.1.10.2.1.16SECTION 516.30
     516.30 Annual reports for a MUMS-designated drug.
21:6.0.1.1.10.2.1.17SECTION 516.31
     516.31 Scope of MUMS-drug exclusive marketing rights.
21:6.0.1.1.10.2.1.18SECTION 516.34
     516.34 FDA recognition of exclusive marketing rights.
21:6.0.1.1.10.2.1.19SECTION 516.36
     516.36 Insufficient quantities of MUMS-designated drugs.
21:6.0.1.1.10.2.1.20SECTION 516.52
     516.52 Availability for public disclosure of data and information in requests.
21:6.0.1.1.10.3SUBPART C
Subpart C - Index of Legally Marketed Unapproved New Animal Drugs for Minor Species
21:6.0.1.1.10.3.1.1SECTION 516.111
     516.111 Scope of this subpart.
21:6.0.1.1.10.3.1.2SECTION 516.115
     516.115 Definitions.
21:6.0.1.1.10.3.1.3SECTION 516.117
     516.117 Submission of correspondence under this subpart.
21:6.0.1.1.10.3.1.4SECTION 516.119
     516.119 Permanent-resident U.S. agent for foreign requestors and holders.
21:6.0.1.1.10.3.1.5SECTION 516.121
     516.121 Meetings.
21:6.0.1.1.10.3.1.6SECTION 516.123
     516.123 Informal conferences regarding agency administrative actions.
21:6.0.1.1.10.3.1.7SECTION 516.125
     516.125 Investigational use of minor species new animal drugs to support indexing.
21:6.0.1.1.10.3.1.8SECTION 516.129
     516.129 Content and format of a request for determination of eligibility for indexing.
21:6.0.1.1.10.3.1.9SECTION 516.131
     516.131 Refuse to file a request for determination of eligibility for indexing.
21:6.0.1.1.10.3.1.10SECTION 516.133
     516.133 Denying a request for determination of eligibility for indexing.
21:6.0.1.1.10.3.1.11SECTION 516.135
     516.135 Granting a request for determination of eligibility for indexing.
21:6.0.1.1.10.3.1.12SECTION 516.137
     516.137 Notification of decision regarding eligibility for indexing.
21:6.0.1.1.10.3.1.13SECTION 516.141
     516.141 Qualified expert panels.
21:6.0.1.1.10.3.1.14SECTION 516.143
     516.143 Written report.
21:6.0.1.1.10.3.1.15SECTION 516.145
     516.145 Content and format of a request for addition to the index.
21:6.0.1.1.10.3.1.16SECTION 516.147
     516.147 Refuse to file a request for addition to the index.
21:6.0.1.1.10.3.1.17SECTION 516.149
     516.149 Denying a request for addition to the index.
21:6.0.1.1.10.3.1.18SECTION 516.151
     516.151 Granting a request for addition to the index.
21:6.0.1.1.10.3.1.19SECTION 516.153
     516.153 Notification of decision regarding index listing.
21:6.0.1.1.10.3.1.20SECTION 516.155
     516.155 Labeling of indexed drugs.
21:6.0.1.1.10.3.1.21SECTION 516.157
     516.157 Publication of the index and content of an index listing.
21:6.0.1.1.10.3.1.22SECTION 516.161
     516.161 Modifications to indexed drugs.
21:6.0.1.1.10.3.1.23SECTION 516.163
     516.163 Change in ownership of an index file.
21:6.0.1.1.10.3.1.24SECTION 516.165
     516.165 Records and reports.
21:6.0.1.1.10.3.1.25SECTION 516.167
     516.167 Removal from the index.
21:6.0.1.1.10.3.1.26SECTION 516.171
     516.171 Confidentiality of data and information in an index file.
21:6.0.1.1.10.4SUBPART D
Subpart D [Reserved]
21:6.0.1.1.10.5SUBPART E
Subpart E - Conditionally Approved New Animal Drugs For Minor Use and Minor Species
21:6.0.1.1.10.5.1.1SECTION 516.1684
     516.1684 Paclitaxel.
21:6.0.1.1.10.5.1.2SECTION 516.2065
     516.2065 Rabacfosadine.
21:6.0.1.1.11PART 520
PART 520 - ORAL DOSAGE FORM NEW ANIMAL DRUGS
21:6.0.1.1.11.0.1.1SECTION 520.23
     520.23 Acepromazine.
21:6.0.1.1.11.0.1.2SECTION 520.28
     520.28 Acetazolamide.
21:6.0.1.1.11.0.1.3SECTION 520.38
     520.38 Albendazole oral dosage forms.
21:6.0.1.1.11.0.1.4SECTION 520.38a
     520.38a Albendazole suspension.
21:6.0.1.1.11.0.1.5SECTION 520.38b
     520.38b Albendazole paste.
21:6.0.1.1.11.0.1.6SECTION 520.43
     520.43 Afoxolaner.
21:6.0.1.1.11.0.1.7SECTION 520.48
     520.48 Altrenogest.
21:6.0.1.1.11.0.1.8SECTION 520.62
     520.62 Aminopentamide.
21:6.0.1.1.11.0.1.9SECTION 520.82
     520.82 Aminopropazine oral dosage forms.
21:6.0.1.1.11.0.1.10SECTION 520.82a
     520.82a Aminopropazine.
21:6.0.1.1.11.0.1.11SECTION 520.82b
     520.82b Aminopropazine and neomycin.
21:6.0.1.1.11.0.1.12SECTION 520.88
     520.88 Amoxicillin oral dosage forms.
21:6.0.1.1.11.0.1.13SECTION 520.88a
     520.88a Amoxicillin trihydrate film-coated tablets.
21:6.0.1.1.11.0.1.14SECTION 520.88b
     520.88b Amoxicillin trihydrate for oral suspension.
21:6.0.1.1.11.0.1.15SECTION 520.88c
     520.88c Amoxicillin trihydrate oral suspension.
21:6.0.1.1.11.0.1.16SECTION 520.88d
     520.88d Amoxicillin trihydrate soluble powder.
21:6.0.1.1.11.0.1.17SECTION 520.88e
     520.88e Amoxicillin trihydrate boluses.
21:6.0.1.1.11.0.1.18SECTION 520.88f
     520.88f Amoxicillin trihydrate tablets.
21:6.0.1.1.11.0.1.19SECTION 520.88g
     520.88g Amoxicillin trihydrate and clavulanate potassium tablets.
21:6.0.1.1.11.0.1.20SECTION 520.88h
     520.88h Amoxicillin trihydrate and clavulanate potassium for oral suspension.
21:6.0.1.1.11.0.1.21SECTION 520.90
     520.90 Ampicillin oral dosage forms.
21:6.0.1.1.11.0.1.22SECTION 520.90a
     520.90a Ampicillin tablets.
21:6.0.1.1.11.0.1.23SECTION 520.90b
     520.90b Ampicillin capsules.
21:6.0.1.1.11.0.1.24SECTION 520.90c
     520.90c Ampicillin boluses.
21:6.0.1.1.11.0.1.25SECTION 520.100
     520.100 Amprolium.
21:6.0.1.1.11.0.1.26SECTION 520.110
     520.110 Apramycin sulfate soluble powder.
21:6.0.1.1.11.0.1.27SECTION 520.154
     520.154 Bacitracin oral dosage forms.
21:6.0.1.1.11.0.1.28SECTION 520.154a
     520.154a Bacitracin methylenedisalicylate.
21:6.0.1.1.11.0.1.29SECTION 520.154b
     520.154b Bacitracin methylenedisalicylate and streptomycin sulfate powder.
21:6.0.1.1.11.0.1.30SECTION 520.154c
     520.154c Bacitracin zinc soluble powder.
21:6.0.1.1.11.0.1.31SECTION 520.222
     520.222 Bunamidine hydrochloride.
21:6.0.1.1.11.0.1.32SECTION 520.246
     520.246 Butorphanol tablets.
21:6.0.1.1.11.0.1.33SECTION 520.260
     520.260 n-Butyl chloride.
21:6.0.1.1.11.0.1.34SECTION 520.284
     520.284 Cambendazole oral dosage forms.
21:6.0.1.1.11.0.1.35SECTION 520.284a
     520.284a Cambendazole suspension.
21:6.0.1.1.11.0.1.36SECTION 520.284b
     520.284b Cambendazole pellets.
21:6.0.1.1.11.0.1.37SECTION 520.284c
     520.284c Cambendazole paste.
21:6.0.1.1.11.0.1.38SECTION 520.292
     520.292 Capromorelin.
21:6.0.1.1.11.0.1.39SECTION 520.301
     520.301 Caramiphen ethanedisulfonate and ammonium chloride tablets.
21:6.0.1.1.11.0.1.40SECTION 520.302
     520.302 Carnidazole tablets.
21:6.0.1.1.11.0.1.41SECTION 520.304
     520.304 Carprofen.
21:6.0.1.1.11.0.1.42SECTION 520.314
     520.314 Cefadroxil.
21:6.0.1.1.11.0.1.43SECTION 520.370
     520.370 Cefpodoxime tablets.
21:6.0.1.1.11.0.1.44SECTION 520.376
     520.376 Cephalexin.
21:6.0.1.1.11.0.1.45SECTION 520.390
     520.390 Chloramphenicol oral dosage forms.
21:6.0.1.1.11.0.1.46SECTION 520.390a
     520.390a Chloramphenicol tablets.
21:6.0.1.1.11.0.1.47SECTION 520.390b
     520.390b Chloramphenicol capsules.
21:6.0.1.1.11.0.1.48SECTION 520.390c
     520.390c Chloramphenicol palmitate oral suspension.
21:6.0.1.1.11.0.1.49SECTION 520.420
     520.420 Chlorothiazide.
21:6.0.1.1.11.0.1.50SECTION 520.434
     520.434 Chlorphenesin carbamate tablets.
21:6.0.1.1.11.0.1.51SECTION 520.441
     520.441 Chlortetracycline powder.
21:6.0.1.1.11.0.1.52SECTION 520.443
     520.443 Chlortetracycline tablets and boluses.
21:6.0.1.1.11.0.1.53SECTION 520.445
     520.445 Chlortetracycline and sulfamethazine powder.
21:6.0.1.1.11.0.1.54SECTION 520.446
     520.446 Clindamycin capsules and tablets.
21:6.0.1.1.11.0.1.55SECTION 520.447
     520.447 Clindamycin solution.
21:6.0.1.1.11.0.1.56SECTION 520.452
     520.452 Clenbuterol syrup.
21:6.0.1.1.11.0.1.57SECTION 520.455
     520.455 Clomipramine tablets.
21:6.0.1.1.11.0.1.58SECTION 520.462
     520.462 Clorsulon drench.
21:6.0.1.1.11.0.1.59SECTION 520.522
     520.522 Cyclosporine.
21:6.0.1.1.11.0.1.60SECTION 520.530
     520.530 Cythioate oral liquid.
21:6.0.1.1.11.0.1.61SECTION 520.531
     520.531 Cythioate tablets.
21:6.0.1.1.11.0.1.62SECTION 520.534
     520.534 Decoquinate.
21:6.0.1.1.11.0.1.63SECTION 520.538
     520.538 Deracoxib.
21:6.0.1.1.11.0.1.64SECTION 520.540
     520.540 Dexamethasone oral dosage forms.
21:6.0.1.1.11.0.1.65SECTION 520.540a
     520.540a Dexamethasone powder.
21:6.0.1.1.11.0.1.66SECTION 520.540b
     520.540b Dexamethasone tablets and boluses.
21:6.0.1.1.11.0.1.67SECTION 520.540c
     520.540c Dexamethasone chewable tablets.
21:6.0.1.1.11.0.1.68SECTION 520.563
     520.563 Dexamethasone chewable tablets.
21:6.0.1.1.11.0.1.69SECTION 520.580
     520.580 Dichlorophene and toluene.
21:6.0.1.1.11.0.1.70SECTION 520.581
     520.581 Dichlorophene tablets.
21:6.0.1.1.11.0.1.71SECTION 520.596
     520.596 Dichlorvos powder.
21:6.0.1.1.11.0.1.72SECTION 520.598
     520.598 Dichlorvos tablets.
21:6.0.1.1.11.0.1.73SECTION 520.600
     520.600 Dichlorvos capsules and pellets.
21:6.0.1.1.11.0.1.74SECTION 520.602
     520.602 Dichlorvos gel.
21:6.0.1.1.11.0.1.75SECTION 520.606
     520.606 Diclazuril.
21:6.0.1.1.11.0.1.76SECTION 520.608
     520.608 Dicloxacillin.
21:6.0.1.1.11.0.1.77SECTION 520.620
     520.620 Diethylcarbamazine oral dosage forms.
21:6.0.1.1.11.0.1.78SECTION 520.622
     520.622 Diethylcarbamazine citrate oral dosage forms.
21:6.0.1.1.11.0.1.79SECTION 520.622a
     520.622a Diethylcarbamazine citrate tablets.
21:6.0.1.1.11.0.1.80SECTION 520.622b
     520.622b Diethylcarbamazine citrate syrup.
21:6.0.1.1.11.0.1.81SECTION 520.622c
     520.622c Diethylcarbamazine citrate chewable tablets.
21:6.0.1.1.11.0.1.82SECTION 520.623
     520.623 Diethylcarbamazine and oxibendazole chewable tablets.
21:6.0.1.1.11.0.1.83SECTION 520.645
     520.645 Difloxacin.
21:6.0.1.1.11.0.1.84SECTION 520.666
     520.666 Dirlotapide.
21:6.0.1.1.11.0.1.85SECTION 520.763
     520.763 Dithiazanine oral dosage forms.
21:6.0.1.1.11.0.1.86SECTION 520.763a
     520.763a Dithiazanine tablets.
21:6.0.1.1.11.0.1.87SECTION 520.763b
     520.763b Dithiazanine powder.
21:6.0.1.1.11.0.1.88SECTION 520.763c
     520.763c Dithiazanine iodide and piperazine citrate suspension.
21:6.0.1.1.11.0.1.89SECTION 520.766
     520.766 Domperidone.
21:6.0.1.1.11.0.1.90SECTION 520.784
     520.784 Doxylamine.
21:6.0.1.1.11.0.1.91SECTION 520.804
     520.804 Enalapril.
21:6.0.1.1.11.0.1.92SECTION 520.812
     520.812 Enrofloxacin.
21:6.0.1.1.11.0.1.93SECTION 520.816
     520.816 Epsiprantel.
21:6.0.1.1.11.0.1.94SECTION 520.823
     520.823 Erythromycin.
21:6.0.1.1.11.0.1.95SECTION 520.852
     520.852 Estriol.
21:6.0.1.1.11.0.1.96SECTION 520.863
     520.863 Ethylisobutrazine.
21:6.0.1.1.11.0.1.97SECTION 520.870
     520.870 Etodolac.
21:6.0.1.1.11.0.1.98SECTION 520.903
     520.903 Febantel oral dosage forms.
21:6.0.1.1.11.0.1.99SECTION 520.903a
     520.903a Febantel paste.
21:6.0.1.1.11.0.1.100SECTION 520.903b
     520.903b Febantel suspension.
21:6.0.1.1.11.0.1.101SECTION 520.903c
     520.903c Febantel and praziquantel paste.
21:6.0.1.1.11.0.1.102SECTION 520.903d
     520.903d Febantel tablets.
21:6.0.1.1.11.0.1.103SECTION 520.905
     520.905 Fenbendazole oral dosage forms.
21:6.0.1.1.11.0.1.104SECTION 520.905a
     520.905a Fenbendazole suspension.
21:6.0.1.1.11.0.1.105SECTION 520.905b
     520.905b Fenbendazole granules.
21:6.0.1.1.11.0.1.106SECTION 520.905c
     520.905c Fenbendazole paste.
21:6.0.1.1.11.0.1.107SECTION 520.905d
     520.905d Fenbendazole powder.
21:6.0.1.1.11.0.1.108SECTION 520.905e
     520.905e Fenbendazole blocks.
21:6.0.1.1.11.0.1.109SECTION 520.928
     520.928 Firocoxib tablets.
21:6.0.1.1.11.0.1.110SECTION 520.930
     520.930 Firocoxib paste.
21:6.0.1.1.11.0.1.111SECTION 520.955
     520.955 Florfenicol.
21:6.0.1.1.11.0.1.112SECTION 520.960
     520.960 Flumethasone.
21:6.0.1.1.11.0.1.113SECTION 520.970
     520.970 Flunixin.
21:6.0.1.1.11.0.1.114SECTION 520.980
     520.980 Fluoxetine.
21:6.0.1.1.11.0.1.115SECTION 520.998
     520.998 Fluralaner.
21:6.0.1.1.11.0.1.116SECTION 520.1010
     520.1010 Furosemide.
21:6.0.1.1.11.0.1.117SECTION 520.1044
     520.1044 Gentamicin sulfate oral dosage forms.
21:6.0.1.1.11.0.1.118SECTION 520.1044a
     520.1044a Gentamicin sulfate oral solution.
21:6.0.1.1.11.0.1.119SECTION 520.1044b
     520.1044b Gentamicin sulfate pig pump oral solution.
21:6.0.1.1.11.0.1.120SECTION 520.1044c
     520.1044c Gentamicin sulfate powder.
21:6.0.1.1.11.0.1.121SECTION 520.1060
     520.1060 Glucose and glycine.
21:6.0.1.1.11.0.1.122SECTION 520.1084
     520.1084 Grapiprant.
21:6.0.1.1.11.0.1.123SECTION 520.1100
     520.1100 Griseofulvin.
21:6.0.1.1.11.0.1.124SECTION 520.1120
     520.1120 Haloxon oral dosage forms.
21:6.0.1.1.11.0.1.125SECTION 520.1120a
     520.1120a Haloxon drench.
21:6.0.1.1.11.0.1.126SECTION 520.1120b
     520.1120b Haloxon boluses.
21:6.0.1.1.11.0.1.127SECTION 520.1130
     520.1130 Hetacillin.
21:6.0.1.1.11.0.1.128SECTION 520.1150
     520.1150 Imepitoin.
21:6.0.1.1.11.0.1.129SECTION 520.1156
     520.1156 Imidacloprid.
21:6.0.1.1.11.0.1.130SECTION 520.1157
     520.1157 Iodinated casein.
21:6.0.1.1.11.0.1.131SECTION 520.1158
     520.1158 Iodochlorhydroxyquin.
21:6.0.1.1.11.0.1.132SECTION 520.1189
     520.1189 Itraconazole.
21:6.0.1.1.11.0.1.133SECTION 520.1192
     520.1192 Ivermectin paste.
21:6.0.1.1.11.0.1.134SECTION 520.1193
     520.1193 Ivermectin tablets and chewables.
21:6.0.1.1.11.0.1.135SECTION 520.1194
     520.1194 Ivermectin meal.
21:6.0.1.1.11.0.1.136SECTION 520.1195
     520.1195 Ivermectin liquid.
21:6.0.1.1.11.0.1.137SECTION 520.1196
     520.1196 Ivermectin and pyrantel tablets.
21:6.0.1.1.11.0.1.138SECTION 520.1197
     520.1197 Ivermectin sustained-release bolus.
21:6.0.1.1.11.0.1.139SECTION 520.1198
     520.1198 Ivermectin and praziquantel paste.
21:6.0.1.1.11.0.1.140SECTION 520.1199
     520.1199 Ivermectin, pyrantel, and praziquantel tablets.
21:6.0.1.1.11.0.1.141SECTION 520.1200
     520.1200 Ivermectin, fenbendazole, and praziquantel tablets.
21:6.0.1.1.11.0.1.142SECTION 520.1204
     520.1204 Kanamycin, bismuth subcarbonate, activated attapulgite.
21:6.0.1.1.11.0.1.143SECTION 520.1242
     520.1242 Levamisole.
21:6.0.1.1.11.0.1.144SECTION 520.1242a
     520.1242a Levamisole powder.
21:6.0.1.1.11.0.1.145SECTION 520.1242b
     520.1242b Levamisol boluses or oblets.
21:6.0.1.1.11.0.1.146SECTION 520.1242c
     520.1242c Levamisol and piperazine.
21:6.0.1.1.11.0.1.147SECTION 520.1242d
     520.1242d Levamisole resinate.
21:6.0.1.1.11.0.1.148SECTION 520.1242e
     520.1242e Levamisole hydrochloride effervescent tablets.
21:6.0.1.1.11.0.1.149SECTION 520.1242f
     520.1242f Levamisol gel.
21:6.0.1.1.11.0.1.150SECTION 520.1242g
     520.1242g Levamisole resinate and famphur paste.
21:6.0.1.1.11.0.1.151SECTION 520.1248
     520.1248 Levothyroxine.
21:6.0.1.1.11.0.1.152SECTION 520.1263
     520.1263 Lincomycin.
21:6.0.1.1.11.0.1.153SECTION 520.1263a
     520.1263a Lincomycin tablets and syrup.
21:6.0.1.1.11.0.1.154SECTION 520.1263b
     520.1263b Lincomycin powder.
21:6.0.1.1.11.0.1.155SECTION 520.1265
     520.1265 Lincomycin and spectinomycin powder.
21:6.0.1.1.11.0.1.156SECTION 520.1284
     520.1284 Liothyronine.
21:6.0.1.1.11.0.1.157SECTION 520.1286
     520.1286 Lotilaner.
21:6.0.1.1.11.0.1.158SECTION 520.1288
     520.1288 Lufenuron tablets.
21:6.0.1.1.11.0.1.159SECTION 520.1289
     520.1289 Lufenuron suspension.
21:6.0.1.1.11.0.1.160SECTION 520.1310
     520.1310 Marbofloxacin.
21:6.0.1.1.11.0.1.161SECTION 520.1315
     520.1315 Maropitant.
21:6.0.1.1.11.0.1.162SECTION 520.1320
     520.1320 Mebendazole.
21:6.0.1.1.11.0.1.163SECTION 520.1326
     520.1326 Mebendazole and trichlorfon oral dosage forms.
21:6.0.1.1.11.0.1.164SECTION 520.1326a
     520.1326a Mebendazole and trichlorfon powder.
21:6.0.1.1.11.0.1.165SECTION 520.1326b
     520.1326b Mebendazole and trichlorfon paste.
21:6.0.1.1.11.0.1.166SECTION 520.1330
     520.1330 Meclofenamic acid granules.
21:6.0.1.1.11.0.1.167SECTION 520.1331
     520.1331 Meclofenamic acid tablets.
21:6.0.1.1.11.0.1.168SECTION 520.1341
     520.1341 Megestrol.
21:6.0.1.1.11.0.1.169SECTION 520.1367
     520.1367 Meloxicam.
21:6.0.1.1.11.0.1.170SECTION 520.1372
     520.1372 Methimazole.
21:6.0.1.1.11.0.1.171SECTION 520.1380
     520.1380 Methocarbamol.
21:6.0.1.1.11.0.1.172SECTION 520.1408
     520.1408 Methylprednisolone.
21:6.0.1.1.11.0.1.173SECTION 520.1409
     520.1409 Methylprednisolone and aspirin.
21:6.0.1.1.11.0.1.174SECTION 520.1422
     520.1422 Metoserpate hydrochloride.
21:6.0.1.1.11.0.1.175SECTION 520.1430
     520.1430 Mibolerone.
21:6.0.1.1.11.0.1.176SECTION 520.1441
     520.1441 Milbemycin.
21:6.0.1.1.11.0.1.177SECTION 520.1443
     520.1443 Milbemycin oxime and lufenuron.
21:6.0.1.1.11.0.1.178SECTION 520.1445
     520.1445 Milbemycin oxime and praziquantel.
21:6.0.1.1.11.0.1.179SECTION 520.1447
     520.1447 Milbemycin oxime, lufenuron, and praziquantel tablets.
21:6.0.1.1.11.0.1.180SECTION 520.1450
     520.1450 Morantel tartrate oral dosage forms.
21:6.0.1.1.11.0.1.181SECTION 520.1450a
     520.1450a Morantel tartrate bolus.
21:6.0.1.1.11.0.1.182SECTION 520.1450b
     520.1450b Morantel tartrate cartridge.
21:6.0.1.1.11.0.1.183SECTION 520.1450c
     520.1450c Morantel tartrate sustained-release trilaminate cylinder/sheet.
21:6.0.1.1.11.0.1.184SECTION 520.1451
     520.1451 Moxidectin tablets.
21:6.0.1.1.11.0.1.185SECTION 520.1452
     520.1452 Moxidectin gel.
21:6.0.1.1.11.0.1.186SECTION 520.1453
     520.1453 Moxidectin and praziquantel gel.
21:6.0.1.1.11.0.1.187SECTION 520.1454
     520.1454 Moxidectin solution.
21:6.0.1.1.11.0.1.188SECTION 520.1468
     520.1468 Naproxen.
21:6.0.1.1.11.0.1.189SECTION 520.1484
     520.1484 Neomycin.
21:6.0.1.1.11.0.1.190SECTION 520.1510
     520.1510 Nitenpyram.
21:6.0.1.1.11.0.1.191SECTION 520.1604
     520.1604 Oclacitinib.
21:6.0.1.1.11.0.1.192SECTION 520.1615
     520.1615 Omeprazole.
21:6.0.1.1.11.0.1.193SECTION 520.1616
     520.1616 Orbifloxacin tablets.
21:6.0.1.1.11.0.1.194SECTION 520.1618
     520.1618 Orbifloxacin suspension.
21:6.0.1.1.11.0.1.195SECTION 520.1628
     520.1628 Oxfendazole powder and pellets.
21:6.0.1.1.11.0.1.196SECTION 520.1629
     520.1629 Oxfendazole paste.
21:6.0.1.1.11.0.1.197SECTION 520.1630
     520.1630 Oxfendazole suspension.
21:6.0.1.1.11.0.1.198SECTION 520.1631
     520.1631 Oxfendazole and trichlorfon paste.
21:6.0.1.1.11.0.1.199SECTION 520.1638
     520.1638 Oxibendazole.
21:6.0.1.1.11.0.1.200SECTION 520.1660
     520.1660 Oxytetracycline.
21:6.0.1.1.11.0.1.201SECTION 520.1660a
     520.1660a Oxytetracycline and carbomycin.
21:6.0.1.1.11.0.1.202SECTION 520.1660b
     520.1660b Oxytetracycline hydrochloride capsules.
21:6.0.1.1.11.0.1.203SECTION 520.1660c
     520.1660c Oxytetracycline hydrochloride tablets/boluses.
21:6.0.1.1.11.0.1.204SECTION 520.1660d
     520.1660d Oxytetracycline powder.
21:6.0.1.1.11.0.1.205SECTION 520.1696
     520.1696 Penicillin.
21:6.0.1.1.11.0.1.206SECTION 520.1696a
     520.1696a Penicillin G powder.
21:6.0.1.1.11.0.1.207SECTION 520.1696b
     520.1696b Penicillin V powder.
21:6.0.1.1.11.0.1.208SECTION 520.1696c
     520.1696c Penicillin V tablets.
21:6.0.1.1.11.0.1.209SECTION 520.1705
     520.1705 Pergolide.
21:6.0.1.1.11.0.1.210SECTION 520.1720
     520.1720 Phenylbutazone oral dosage forms.
21:6.0.1.1.11.0.1.211SECTION 520.1720a
     520.1720a Phenylbutazone tablets and boluses.
21:6.0.1.1.11.0.1.212SECTION 520.1720b
     520.1720b Phenylbutazone granules.
21:6.0.1.1.11.0.1.213SECTION 520.1720c
     520.1720c Phenylbutazone paste.
21:6.0.1.1.11.0.1.214SECTION 520.1720d
     520.1720d Phenylbutazone gel.
21:6.0.1.1.11.0.1.215SECTION 520.1720e
     520.1720e Phenylbutazone powder.
21:6.0.1.1.11.0.1.216SECTION 520.1760
     520.1760 Phenylpropanolamine.
21:6.0.1.1.11.0.1.217SECTION 520.1780
     520.1780 Pimobendan.
21:6.0.1.1.11.0.1.218SECTION 520.1802
     520.1802 Piperazine-carbon disulfide complex oral dosage forms.
21:6.0.1.1.11.0.1.219SECTION 520.1802a
     520.1802a Piperazine-carbon disulfide complex suspension.
21:6.0.1.1.11.0.1.220SECTION 520.1802b
     520.1802b Piperazine-carbon disulfide complex boluses.
21:6.0.1.1.11.0.1.221SECTION 520.1802c
     520.1802c Piperazine-carbon disulfide complex with phenothiazine suspension.
21:6.0.1.1.11.0.1.222SECTION 520.1803
     520.1803 Piperazine citrate capsules.
21:6.0.1.1.11.0.1.223SECTION 520.1805
     520.1805 Piperazine phosphate with thenium closylate tablets.
21:6.0.1.1.11.0.1.224SECTION 520.1806
     520.1806 Piperazine suspension.
21:6.0.1.1.11.0.1.225SECTION 520.1840
     520.1840 Poloxalene.
21:6.0.1.1.11.0.1.226SECTION 520.1846
     520.1846 Polyoxyethylene (23) lauryl ether blocks.
21:6.0.1.1.11.0.1.227SECTION 520.1855
     520.1855 Ponazuril.
21:6.0.1.1.11.0.1.228SECTION 520.1860
     520.1860 Pradofloxacin.
21:6.0.1.1.11.0.1.229SECTION 520.1870
     520.1870 Praziquantel tablets.
21:6.0.1.1.11.0.1.230SECTION 520.1871
     520.1871 Praziquantel and pyrantel.
21:6.0.1.1.11.0.1.231SECTION 520.1872
     520.1872 Praziquantel, pyrantel pamoate, and febantel tablets.
21:6.0.1.1.11.0.1.232SECTION 520.1880
     520.1880 Prednisolone.
21:6.0.1.1.11.0.1.233SECTION 520.1900
     520.1900 Primidone.
21:6.0.1.1.11.0.1.234SECTION 520.1920
     520.1920 Prochlorperazine and isopropamide.
21:6.0.1.1.11.0.1.235SECTION 520.1921
     520.1921 Prochlorperazine, isopropamide, and neomycin.
21:6.0.1.1.11.0.1.236SECTION 520.1962
     520.1962 Promazine.
21:6.0.1.1.11.0.1.237SECTION 520.2002
     520.2002 Propiopromazine.
21:6.0.1.1.11.0.1.238SECTION 520.2041
     520.2041 Pyrantel pamoate chewable tablets.
21:6.0.1.1.11.0.1.239SECTION 520.2042
     520.2042 Pyrantel pamoate tablets.
21:6.0.1.1.11.0.1.240SECTION 520.2043
     520.2043 Pyrantel pamoate suspension.
21:6.0.1.1.11.0.1.241SECTION 520.2044
     520.2044 Pyrantel pamoate paste.
21:6.0.1.1.11.0.1.242SECTION 520.2045
     520.2045 Pyrantel tartrate powder.
21:6.0.1.1.11.0.1.243SECTION 520.2046
     520.2046 Pyrantel tartrate pellets.
21:6.0.1.1.11.0.1.244SECTION 520.2075
     520.2075 Robenacoxib.
21:6.0.1.1.11.0.1.245SECTION 520.2086
     520.2086 Sarolaner.
21:6.0.1.1.11.0.1.246SECTION 520.2098
     520.2098 Selegiline.
21:6.0.1.1.11.0.1.247SECTION 520.2100
     520.2100 Selenium and vitamin E.
21:6.0.1.1.11.0.1.248SECTION 520.2123
     520.2123 Spectinomycin oral dosage forms.
21:6.0.1.1.11.0.1.249SECTION 520.2123a
     520.2123a Spectinomycin tablets.
21:6.0.1.1.11.0.1.250SECTION 520.2123b
     520.2123b Spectinomycin powder.
21:6.0.1.1.11.0.1.251SECTION 520.2123c
     520.2123c Spectinomycin solution.
21:6.0.1.1.11.0.1.252SECTION 520.2130
     520.2130 Spinosad.
21:6.0.1.1.11.0.1.253SECTION 520.2134
     520.2134 Spinosad and milbemycin.
21:6.0.1.1.11.0.1.254SECTION 520.2150
     520.2150 Stanozolol.
21:6.0.1.1.11.0.1.255SECTION 520.2158
     520.2158 Streptomycin.
21:6.0.1.1.11.0.1.256SECTION 520.2170
     520.2170 Sulfabromomethazine.
21:6.0.1.1.11.0.1.257SECTION 520.2184
     520.2184 Sulfachloropyrazine.
21:6.0.1.1.11.0.1.258SECTION 520.2200
     520.2200 Sulfachlorpyridazine.
21:6.0.1.1.11.0.1.259SECTION 520.2215
     520.2215 Sulfadiazine/pyrimethamine suspension.
21:6.0.1.1.11.0.1.260SECTION 520.2218
     520.2218 Sulfamerazine, sulfamethazine, and sulfaquinoxaline powder.
21:6.0.1.1.11.0.1.261SECTION 520.2220
     520.2220 Sulfadimethoxine oral dosage forms.
21:6.0.1.1.11.0.1.262SECTION 520.2220a
     520.2220a Sulfadimethoxine oral solution and soluble powder.
21:6.0.1.1.11.0.1.263SECTION 520.2220b
     520.2220b Sulfadimethoxine suspension.
21:6.0.1.1.11.0.1.264SECTION 520.2220c
     520.2220c Sulfadimethoxine tablet.
21:6.0.1.1.11.0.1.265SECTION 520.2220d
     520.2220d Sulfadimethoxine bolus.
21:6.0.1.1.11.0.1.266SECTION 520.2220e
     520.2220e Sulfadimethoxine extended-release bolus.
21:6.0.1.1.11.0.1.267SECTION 520.2220f
     520.2220f Sulfadimethoxine and ormetoprim tablet.
21:6.0.1.1.11.0.1.268SECTION 520.2240
     520.2240 Sulfaethoxypyridazine.
21:6.0.1.1.11.0.1.269SECTION 520.2240a
     520.2240a Sulfaethoxypyridazine solution.
21:6.0.1.1.11.0.1.270SECTION 520.2240b
     520.2240b Sulfaethoxypyridazine tablets.
21:6.0.1.1.11.0.1.271SECTION 520.2260
     520.2260 Sulfamethazine oral dosage forms.
21:6.0.1.1.11.0.1.272SECTION 520.2260a
     520.2260a Sulfamethazine oblet, tablet, and bolus.
21:6.0.1.1.11.0.1.273SECTION 520.2260b
     520.2260b Sulfamethazine sustained-release boluses.
21:6.0.1.1.11.0.1.274SECTION 520.2260c
     520.2260c Sulfamethazine sustained-release tablets.
21:6.0.1.1.11.0.1.275SECTION 520.2261
     520.2261 Sulfamethazine sodium oral dosage forms.
21:6.0.1.1.11.0.1.276SECTION 520.2261a
     520.2261a Sulfamethazine solution.
21:6.0.1.1.11.0.1.277SECTION 520.2261b
     520.2261b Sulfamethazine powder.
21:6.0.1.1.11.0.1.278SECTION 520.2280
     520.2280 Sulfamethizole and methenamine.
21:6.0.1.1.11.0.1.279SECTION 520.2325
     520.2325 Sulfaquinoxaline oral dosage forms.
21:6.0.1.1.11.0.1.280SECTION 520.2325a
     520.2325a Sulfaquinoxaline powder and solution.
21:6.0.1.1.11.0.1.281SECTION 520.2325b
     520.2325b Sulfaquinoxaline drench.
21:6.0.1.1.11.0.1.282SECTION 520.2330
     520.2330 Sulfisoxazole tablets.
21:6.0.1.1.11.0.1.283SECTION 520.2335
     520.2335 Telmisartan.
21:6.0.1.1.11.0.1.284SECTION 520.2340
     520.2340 Tepoxalin.
21:6.0.1.1.11.0.1.285SECTION 520.2345
     520.2345 Tetracycline.
21:6.0.1.1.11.0.1.286SECTION 520.2345a
     520.2345a Tetracycline capsules.
21:6.0.1.1.11.0.1.287SECTION 520.2345b
     520.2345b Tetracycline tablets.
21:6.0.1.1.11.0.1.288SECTION 520.2345c
     520.2345c Tetracycline boluses.
21:6.0.1.1.11.0.1.289SECTION 520.2345d
     520.2345d Tetracycline powder.
21:6.0.1.1.11.0.1.290SECTION 520.2345e
     520.2345e Tetracycline solution.
21:6.0.1.1.11.0.1.291SECTION 520.2345f
     520.2345f Tetracycline phosphate complex and sodium novobiocin capsules.
21:6.0.1.1.11.0.1.292SECTION 520.2345g
     520.2345g Tetracycline hydrochloride and sodium novobiocin tablets.
21:6.0.1.1.11.0.1.293SECTION 520.2345h
     520.2345h Tetracycline hydrochloride, sodium novobiocin, and prednisolone tablets.
21:6.0.1.1.11.0.1.294SECTION 520.2362
     520.2362 Thenium closylate.
21:6.0.1.1.11.0.1.295SECTION 520.2380
     520.2380 Thiabendazole oral dosage forms.
21:6.0.1.1.11.0.1.296SECTION 520.2380a
     520.2380a Thiabendazole top dressing and mineral protein block.
21:6.0.1.1.11.0.1.297SECTION 520.2380b
     520.2380b Thiabendazole drench or paste.
21:6.0.1.1.11.0.1.298SECTION 520.2380c
     520.2380c Thiabendazole bolus.
21:6.0.1.1.11.0.1.299SECTION 520.2380d
     520.2380d Thiabendazole and piperazine citrate.
21:6.0.1.1.11.0.1.300SECTION 520.2380e
     520.2380e Thiabendazole and piperazine phosphate.
21:6.0.1.1.11.0.1.301SECTION 520.2380f
     520.2380f Thiabendazole and triclorfon.
21:6.0.1.1.11.0.1.302SECTION 520.2455
     520.2455 Tiamulin.
21:6.0.1.1.11.0.1.303SECTION 520.2471
     520.2471 Tilmicosin.
21:6.0.1.1.11.0.1.304SECTION 520.2473
     520.2473 Tioxidazole oral dosage forms.
21:6.0.1.1.11.0.1.305SECTION 520.2473a
     520.2473a Tioxidazole granules.
21:6.0.1.1.11.0.1.306SECTION 520.2473b
     520.2473b Tioxidazole paste.
21:6.0.1.1.11.0.1.307SECTION 520.2475
     520.2475 Toceranib.
21:6.0.1.1.11.0.1.308SECTION 520.2483
     520.2483 Triamcinolone.
21:6.0.1.1.11.0.1.309SECTION 520.2520
     520.2520 Trichlorfon oral dosage forms.
21:6.0.1.1.11.0.1.310SECTION 520.2520a
     520.2520a Trichlorfon and atropine.
21:6.0.1.1.11.0.1.311SECTION 520.2520b
     520.2520b Trichlorfon boluses.
21:6.0.1.1.11.0.1.312SECTION 520.2520c
     520.2520c Trichlorfon granules.
21:6.0.1.1.11.0.1.313SECTION 520.2520d
     520.2520d Trichlorfon, phenothiazine, and piperazine.
21:6.0.1.1.11.0.1.314SECTION 520.2582
     520.2582 Triflupromazine.
21:6.0.1.1.11.0.1.315SECTION 520.2598
     520.2598 Trilostane.
21:6.0.1.1.11.0.1.316SECTION 520.2604
     520.2604 Trimeprazine and prednisolone tablets.
21:6.0.1.1.11.0.1.317SECTION 520.2605
     520.2605 Trimeprazine and prednisolone capsules.
21:6.0.1.1.11.0.1.318SECTION 520.2610
     520.2610 Trimethoprim and sulfadiazine tablets.
21:6.0.1.1.11.0.1.319SECTION 520.2611
     520.2611 Trimethoprim and sulfadiazine paste.
21:6.0.1.1.11.0.1.320SECTION 520.2612
     520.2612 Trimethoprim and sulfadiazine suspension.
21:6.0.1.1.11.0.1.321SECTION 520.2613
     520.2613 Trimethoprim and sulfadiazine powder.
21:6.0.1.1.11.0.1.322SECTION 520.2640
     520.2640 Tylosin.
21:6.0.1.1.11.0.1.323SECTION 520.2645
     520.2645 Tylvalosin.
21:6.0.1.1.12PART 522
PART 522 - IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS
21:6.0.1.1.12.0.1.1SECTION 522.23
     522.23 Acepromazine.
21:6.0.1.1.12.0.1.2SECTION 522.52
     522.52 Alfaxalone.
21:6.0.1.1.12.0.1.3SECTION 522.56
     522.56 Amikacin.
21:6.0.1.1.12.0.1.4SECTION 522.62
     522.62 Aminopentamide.
21:6.0.1.1.12.0.1.5SECTION 522.82
     522.82 Aminopropazine.
21:6.0.1.1.12.0.1.6SECTION 522.84
     522.84 Beta-aminopropionitrile.
21:6.0.1.1.12.0.1.7SECTION 522.88
     522.88 Amoxicillin.
21:6.0.1.1.12.0.1.8SECTION 522.90
     522.90 Ampicillin injectable dosage forms.
21:6.0.1.1.12.0.1.9SECTION 522.90a
     522.90a Ampicillin trihydrate suspension.
21:6.0.1.1.12.0.1.10SECTION 522.90b
     522.90b Ampicillin trihydrate powder for injection.
21:6.0.1.1.12.0.1.11SECTION 522.90c
     522.90c Ampicillin sodium.
21:6.0.1.1.12.0.1.12SECTION 522.144
     522.144 Arsenamide.
21:6.0.1.1.12.0.1.13SECTION 522.147
     522.147 Atipamezole.
21:6.0.1.1.12.0.1.14SECTION 522.150
     522.150 Azaperone.
21:6.0.1.1.12.0.1.15SECTION 522.161
     522.161 Betamethasone.
21:6.0.1.1.12.0.1.16SECTION 522.163
     522.163 Betamethasone dipropionate and betamethasone sodium phosphate aqueous suspension.
21:6.0.1.1.12.0.1.17SECTION 522.167
     522.167 Betamethasone sodium phosphate and betamethasone acetate.
21:6.0.1.1.12.0.1.18SECTION 522.204
     522.204 Boldenone.
21:6.0.1.1.12.0.1.19SECTION 522.224
     522.224 Bupivacaine.
21:6.0.1.1.12.0.1.20SECTION 522.230
     522.230 Buprenorphine.
21:6.0.1.1.12.0.1.21SECTION 522.234
     522.234 Butamisole.
21:6.0.1.1.12.0.1.22SECTION 522.246
     522.246 Butorphanol.
21:6.0.1.1.12.0.1.23SECTION 522.275
     522.275 N-Butylscopolammonium.
21:6.0.1.1.12.0.1.24SECTION 522.304
     522.304 Carprofen.
21:6.0.1.1.12.0.1.25SECTION 522.311
     522.311 Cefovecin.
21:6.0.1.1.12.0.1.26SECTION 522.313
     522.313 Ceftiofur injectable dosage forms.
21:6.0.1.1.12.0.1.27SECTION 522.313a
     522.313a Ceftiofur crystalline free acid.
21:6.0.1.1.12.0.1.28SECTION 522.313b
     522.313b Ceftiofur hydrochloride.
21:6.0.1.1.12.0.1.29SECTION 522.313c
     522.313c Ceftiofur sodium.
21:6.0.1.1.12.0.1.30SECTION 522.380
     522.380 Chloral hydrate, pentobarbital, and magnesium sulfate.
21:6.0.1.1.12.0.1.31SECTION 522.390
     522.390 Chloramphenicol.
21:6.0.1.1.12.0.1.32SECTION 522.454
     522.454 Clodronate.
21:6.0.1.1.12.0.1.33SECTION 522.460
     522.460 Cloprostenol.
21:6.0.1.1.12.0.1.34SECTION 522.468
     522.468 Colistimethate sodium powder for injection.
21:6.0.1.1.12.0.1.35SECTION 522.480
     522.480 Corticotropin.
21:6.0.1.1.12.0.1.36SECTION 522.518
     522.518 Cupric glycinate injection.
21:6.0.1.1.12.0.1.37SECTION 522.522
     522.522 Danofloxacin.
21:6.0.1.1.12.0.1.38SECTION 522.533
     522.533 Deslorelin.
21:6.0.1.1.12.0.1.39SECTION 522.535
     522.535 Desoxycorticosterone.
21:6.0.1.1.12.0.1.40SECTION 522.536
     522.536 Detomidine.
21:6.0.1.1.12.0.1.41SECTION 522.540
     522.540 Dexamethasone solution.
21:6.0.1.1.12.0.1.42SECTION 522.542
     522.542 Dexamethasone suspension.
21:6.0.1.1.12.0.1.43SECTION 522.558
     522.558 Dexmedetomidine.
21:6.0.1.1.12.0.1.44SECTION 522.563
     522.563 Diatrizoate.
21:6.0.1.1.12.0.1.45SECTION 522.650
     522.650 Dihydrostreptomycin sulfate injection.
21:6.0.1.1.12.0.1.46SECTION 522.690
     522.690 Dinoprost.
21:6.0.1.1.12.0.1.47SECTION 522.723
     522.723 Diprenorphine.
21:6.0.1.1.12.0.1.48SECTION 522.728
     522.728 Dipyrone.
21:6.0.1.1.12.0.1.49SECTION 522.770
     522.770 Doramectin.
21:6.0.1.1.12.0.1.50SECTION 522.775
     522.775 Doxapram.
21:6.0.1.1.12.0.1.51SECTION 522.784
     522.784 Doxylamine.
21:6.0.1.1.12.0.1.52SECTION 522.800
     522.800 Droperidol and fentanyl.
21:6.0.1.1.12.0.1.53SECTION 522.810
     522.810 Embutramide, chloroquine, and lidocaine solution.
21:6.0.1.1.12.0.1.54SECTION 522.812
     522.812 Enrofloxacin.
21:6.0.1.1.12.0.1.55SECTION 522.814
     522.814 Eprinomectin.
21:6.0.1.1.12.0.1.56SECTION 522.820
     522.820 Erythromycin.
21:6.0.1.1.12.0.1.57SECTION 522.840
     522.840 Estradiol.
21:6.0.1.1.12.0.1.58SECTION 522.842
     522.842 Estradiol benzoate and testosterone propionate.
21:6.0.1.1.12.0.1.59SECTION 522.850
     522.850 Estradiol valerate and norgestomet in combination.
21:6.0.1.1.12.0.1.60SECTION 522.863
     522.863 Ethylisobutrazine.
21:6.0.1.1.12.0.1.61SECTION 522.870
     522.870 Etodolac.
21:6.0.1.1.12.0.1.62SECTION 522.883
     522.883 Etorphine.
21:6.0.1.1.12.0.1.63SECTION 522.914
     522.914 Fenprostalene.
21:6.0.1.1.12.0.1.64SECTION 522.930
     522.930 Firocoxib.
21:6.0.1.1.12.0.1.65SECTION 522.955
     522.955 Florfenicol.
21:6.0.1.1.12.0.1.66SECTION 522.956
     522.956 Florfenicol and flunixin.
21:6.0.1.1.12.0.1.67SECTION 522.960
     522.960 Flumethasone injectable dosage forms.
21:6.0.1.1.12.0.1.68SECTION 522.960a
     522.960a Flumethasone suspension.
21:6.0.1.1.12.0.1.69SECTION 522.960b
     522.960b Flumethasone acetate solution.
21:6.0.1.1.12.0.1.70SECTION 522.960c
     522.960c Flumethasone solution.
21:6.0.1.1.12.0.1.71SECTION 522.970
     522.970 Flunixin.
21:6.0.1.1.12.0.1.72SECTION 522.995
     522.995 Fluprostenol.
21:6.0.1.1.12.0.1.73SECTION 522.1002
     522.1002 Follicle stimulating hormone.
21:6.0.1.1.12.0.1.74SECTION 522.1010
     522.1010 Furosemide.
21:6.0.1.1.12.0.1.75SECTION 522.1014
     522.1014 Gamithromycin.
21:6.0.1.1.12.0.1.76SECTION 522.1020
     522.1020 Gelatin.
21:6.0.1.1.12.0.1.77SECTION 522.1044
     522.1044 Gentamicin.
21:6.0.1.1.12.0.1.78SECTION 522.1055
     522.1055 Gleptoferron.
21:6.0.1.1.12.0.1.79SECTION 522.1066
     522.1066 Glycopyrrolate.
21:6.0.1.1.12.0.1.80SECTION 522.1077
     522.1077 Gonadorelin.
21:6.0.1.1.12.0.1.81SECTION 522.1079
     522.1079 Serum gonadotropin and chorionic gonadotropin.
21:6.0.1.1.12.0.1.82SECTION 522.1081
     522.1081 Chorionic gonadotropin.
21:6.0.1.1.12.0.1.83SECTION 522.1083
     522.1083 Gonadotropin releasing factor analog-diphtheria toxoid conjugate.
21:6.0.1.1.12.0.1.84SECTION 522.1085
     522.1085 Guaifenesin powder for injection.
21:6.0.1.1.12.0.1.85SECTION 522.1086
     522.1086 Guaifenesin solution.
21:6.0.1.1.12.0.1.86SECTION 522.1125
     522.1125 Hemoglobin glutamer-200 (bovine).
21:6.0.1.1.12.0.1.87SECTION 522.1145
     522.1145 Hyaluronate.
21:6.0.1.1.12.0.1.88SECTION 522.1150
     522.1150 Hydrochlorothiazide.
21:6.0.1.1.12.0.1.89SECTION 522.1155
     522.1155 Imidocarb powder for injection.
21:6.0.1.1.12.0.1.90SECTION 522.1156
     522.1156 Imidocarb solution.
21:6.0.1.1.12.0.1.91SECTION 522.1160
     522.1160 Insulin.
21:6.0.1.1.12.0.1.92SECTION 522.1182
     522.1182 Iron injection.
21:6.0.1.1.12.0.1.93SECTION 522.1185
     522.1185 Isoflupredone.
21:6.0.1.1.12.0.1.94SECTION 522.1192
     522.1192 Ivermectin.
21:6.0.1.1.12.0.1.95SECTION 522.1193
     522.1193 Ivermectin and clorsulon.
21:6.0.1.1.12.0.1.96SECTION 522.1204
     522.1204 Kanamycin.
21:6.0.1.1.12.0.1.97SECTION 522.1222
     522.1222 Ketamine.
21:6.0.1.1.12.0.1.98SECTION 522.1223
     522.1223 Ketamine, promazine, and aminopentamide.
21:6.0.1.1.12.0.1.99SECTION 522.1225
     522.1225 Ketoprofen.
21:6.0.1.1.12.0.1.100SECTION 522.1242
     522.1242 Levamisole.
21:6.0.1.1.12.0.1.101SECTION 522.1260
     522.1260 Lincomycin.
21:6.0.1.1.12.0.1.102SECTION 522.1289
     522.1289 Lufenuron.
21:6.0.1.1.12.0.1.103SECTION 522.1290
     522.1290 Luprostiol.
21:6.0.1.1.12.0.1.104SECTION 522.1315
     522.1315 Maropitant.
21:6.0.1.1.12.0.1.105SECTION 522.1335
     522.1335 Medetomidine.
21:6.0.1.1.12.0.1.106SECTION 522.1350
     522.1350 Melatonin implant.
21:6.0.1.1.12.0.1.107SECTION 522.1362
     522.1362 Melarsomine powder for injection.
21:6.0.1.1.12.0.1.108SECTION 522.1367
     522.1367 Meloxicam.
21:6.0.1.1.12.0.1.109SECTION 522.1372
     522.1372 Mepivacaine.
21:6.0.1.1.12.0.1.110SECTION 522.1380
     522.1380 Methocarbamol.
21:6.0.1.1.12.0.1.111SECTION 522.1410
     522.1410 Methylprednisolone.
21:6.0.1.1.12.0.1.112SECTION 522.1450
     522.1450 Moxidectin solution.
21:6.0.1.1.12.0.1.113SECTION 522.1451
     522.1451 Moxidectin microspheres for injection.
21:6.0.1.1.12.0.1.114SECTION 522.1452
     522.1452 Nalorphine.
21:6.0.1.1.12.0.1.115SECTION 522.1465
     522.1465 Naltrexone.
21:6.0.1.1.12.0.1.116SECTION 522.1468
     522.1468 Naproxen for injection.
21:6.0.1.1.12.0.1.117SECTION 522.1484
     522.1484 Neomycin.
21:6.0.1.1.12.0.1.118SECTION 522.1503
     522.1503 Neostigmine.
21:6.0.1.1.12.0.1.119SECTION 522.1610
     522.1610 Oleate sodium.
21:6.0.1.1.12.0.1.120SECTION 522.1620
     522.1620 Orgotein for injection.
21:6.0.1.1.12.0.1.121SECTION 522.1660
     522.1660 Oxytetracycline injectable dosage forms.
21:6.0.1.1.12.0.1.122SECTION 522.1660a
     522.1660a Oxytetracycline solution, 200 milligrams/milliliter.
21:6.0.1.1.12.0.1.123SECTION 522.1660b
     522.1660b Oxytetracycline solution, 300 milligrams/milliliter.
21:6.0.1.1.12.0.1.124SECTION 522.1662
     522.1662 Oxytetracycline hydrochloride implantation or injectable dosage forms.
21:6.0.1.1.12.0.1.125SECTION 522.1662a
     522.1662a Oxytetracycline hydrochloride injection.
21:6.0.1.1.12.0.1.126SECTION 522.1662b
     522.1662b Oxytetracycline hydrochloride with lidocaine injection.
21:6.0.1.1.12.0.1.127SECTION 522.1664
     522.1664 Oxytetracycline and flunixin.
21:6.0.1.1.12.0.1.128SECTION 522.1680
     522.1680 Oxytocin.
21:6.0.1.1.12.0.1.129SECTION 522.1684
     522.1684 Pegbovigrastim.
21:6.0.1.1.12.0.1.130SECTION 522.1696
     522.1696 Penicillin G procaine injectable dosage forms.
21:6.0.1.1.12.0.1.131SECTION 522.1696a
     522.1696a Penicillin G benzathine and penicillin G procaine suspension.
21:6.0.1.1.12.0.1.132SECTION 522.1696b
     522.1696b Penicillin G procaine aqueous suspension.
21:6.0.1.1.12.0.1.133SECTION 522.1696c
     522.1696c Penicillin G procaine in oil.
21:6.0.1.1.12.0.1.134SECTION 522.1697
     522.1697 Pentobarbital and phenytoin.
21:6.0.1.1.12.0.1.135SECTION 522.1698
     522.1698 Pentazocine.
21:6.0.1.1.12.0.1.136SECTION 522.1704
     522.1704 Pentobarbital.
21:6.0.1.1.12.0.1.137SECTION 522.1720
     522.1720 Phenylbutazone.
21:6.0.1.1.12.0.1.138SECTION 522.1820
     522.1820 Pituitary luteinizing hormone powder for injection.
21:6.0.1.1.12.0.1.139SECTION 522.1850
     522.1850 Polysulfated glycosaminoglycan.
21:6.0.1.1.12.0.1.140SECTION 522.1862
     522.1862 Pralidoxime powder for injection.
21:6.0.1.1.12.0.1.141SECTION 522.1870
     522.1870 Praziquantel.
21:6.0.1.1.12.0.1.142SECTION 522.1881
     522.1881 Prednisolone acetate.
21:6.0.1.1.12.0.1.143SECTION 522.1883
     522.1883 Prednisolone sodium phosphate.
21:6.0.1.1.12.0.1.144SECTION 522.1884
     522.1884 Prednisolone sodium succinate.
21:6.0.1.1.12.0.1.145SECTION 522.1885
     522.1885 Prednisolone tertiary butylacetate.
21:6.0.1.1.12.0.1.146SECTION 522.1890
     522.1890 Sterile prednisone suspension.
21:6.0.1.1.12.0.1.147SECTION 522.1920
     522.1920 Prochlorperazine and isopropamide.
21:6.0.1.1.12.0.1.148SECTION 522.1940
     522.1940 Progesterone and estradiol benzoate.
21:6.0.1.1.12.0.1.149SECTION 522.1962
     522.1962 Promazine.
21:6.0.1.1.12.0.1.150SECTION 522.2002
     522.2002 Propiopromazine.
21:6.0.1.1.12.0.1.151SECTION 522.2005
     522.2005 Propofol.
21:6.0.1.1.12.0.1.152SECTION 522.2012
     522.2012 Prostalene.
21:6.0.1.1.12.0.1.153SECTION 522.2063
     522.2063 Pyrilamine.
21:6.0.1.1.12.0.1.154SECTION 522.2075
     522.2075 Robenacoxib.
21:6.0.1.1.12.0.1.155SECTION 522.2076
     522.2076 Romifidine.
21:6.0.1.1.12.0.1.156SECTION 522.2092
     522.2092 Secobarbital and dibucaine.
21:6.0.1.1.12.0.1.157SECTION 522.2100
     522.2100 Selenium and vitamin E.
21:6.0.1.1.12.0.1.158SECTION 522.2112
     522.2112 Sometribove zinc suspension.
21:6.0.1.1.12.0.1.159SECTION 522.2120
     522.2120 Spectinomycin dihydrochloride injection.
21:6.0.1.1.12.0.1.160SECTION 522.2121
     522.2121 Spectinomycin sulfate.
21:6.0.1.1.12.0.1.161SECTION 522.2150
     522.2150 Stanozolol.
21:6.0.1.1.12.0.1.162SECTION 522.2200
     522.2200 Sulfachlorpyridazine.
21:6.0.1.1.12.0.1.163SECTION 522.2220
     522.2220 Sulfadimethoxine.
21:6.0.1.1.12.0.1.164SECTION 522.2240
     522.2240 Sulfaethoxypyridazine.
21:6.0.1.1.12.0.1.165SECTION 522.2260
     522.2260 Sulfamethazine.
21:6.0.1.1.12.0.1.166SECTION 522.2340
     522.2340 Sulfomyxin.
21:6.0.1.1.12.0.1.167SECTION 522.2404
     522.2404 Thialbarbitone sodium for injection.
21:6.0.1.1.12.0.1.168SECTION 522.2424
     522.2424 Thiamylal.
21:6.0.1.1.12.0.1.169SECTION 522.2444
     522.2444 Thiopental injectable dosage forms.
21:6.0.1.1.12.0.1.170SECTION 522.2444a
     522.2444a Thiopental powder for injection.
21:6.0.1.1.12.0.1.171SECTION 522.2444b
     522.2444b Thiopental and pentobarbital powder for injection.
21:6.0.1.1.12.0.1.172SECTION 522.2460
     522.2460 Tildipirosin.
21:6.0.1.1.12.0.1.173SECTION 522.2470
     522.2470 Tiletamine and zolazepam for injection.
21:6.0.1.1.12.0.1.174SECTION 522.2471
     522.2471 Tilmicosin.
21:6.0.1.1.12.0.1.175SECTION 522.2473
     522.2473 Tiludronate.
21:6.0.1.1.12.0.1.176SECTION 522.2474
     522.2474 Tolazoline.
21:6.0.1.1.12.0.1.177SECTION 522.2476
     522.2476 Trenbolone acetate.
21:6.0.1.1.12.0.1.178SECTION 522.2477
     522.2477 Trenbolone acetate and estradiol.
21:6.0.1.1.12.0.1.179SECTION 522.2478
     522.2478 Trenbolone acetate and estradiol benzoate.
21:6.0.1.1.12.0.1.180SECTION 522.2483
     522.2483 Triamcinolone.
21:6.0.1.1.12.0.1.181SECTION 522.2582
     522.2582 Triflupromazine.
21:6.0.1.1.12.0.1.182SECTION 522.2610
     522.2610 Trimethoprim and sulfadiazine.
21:6.0.1.1.12.0.1.183SECTION 522.2615
     522.2615 Tripelennamine.
21:6.0.1.1.12.0.1.184SECTION 522.2630
     522.2630 Tulathromycin.
21:6.0.1.1.12.0.1.185SECTION 522.2640
     522.2640 Tylosin.
21:6.0.1.1.12.0.1.186SECTION 522.2662
     522.2662 Xylazine.
21:6.0.1.1.12.0.1.187SECTION 522.2670
     522.2670 Yohimbine.
21:6.0.1.1.12.0.1.188SECTION 522.2680
     522.2680 Zeranol.
21:6.0.1.1.12.0.1.189SECTION 522.2690
     522.2690 Zinc gluconate.
21:6.0.1.1.13PART 524
PART 524 - OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS
21:6.0.1.1.13.0.1SUBJGRP 1
  Fluocinolone Topical and Otic Dosage Forms
21:6.0.1.1.13.0.1.1SECTION 524.86
     524.86 Amitraz.
21:6.0.1.1.13.0.1.2SECTION 524.154
     524.154 Bacitracin, neomycin, and polymyxin B ophthalmic ointment.
21:6.0.1.1.13.0.1.3SECTION 524.155
     524.155 Bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic ointment.
21:6.0.1.1.13.0.1.4SECTION 524.390
     524.390 Chloramphenicol ophthalmic ointment.
21:6.0.1.1.13.0.1.5SECTION 524.402
     524.402 Chlorhexidine.
21:6.0.1.1.13.0.1.6SECTION 524.450
     524.450 Clotrimazole.
21:6.0.1.1.13.0.1.7SECTION 524.463
     524.463 Copper naphthenate.
21:6.0.1.1.13.0.1.8SECTION 524.575
     524.575 Cyclosporine ophthalmic ointment.
21:6.0.1.1.13.0.1.9SECTION 524.590
     524.590 Diclofenac.
21:6.0.1.1.13.0.1.10SECTION 524.660
     524.660 Dimethyl sulfoxide.
21:6.0.1.1.13.0.1.11SECTION 524.770
     524.770 Doramectin.
21:6.0.1.1.13.0.1.12SECTION 524.775
     524.775 Emodepside and praziquantel.
21:6.0.1.1.13.0.1.13SECTION 524.802
     524.802 Enrofloxacin and silver sulfadiazine otic emulsion.
21:6.0.1.1.13.0.1.14SECTION 524.814
     524.814 Eprinomectin.
21:6.0.1.1.13.0.1.15SECTION 524.815
     524.815 Eprinomectin and praziquantel.
21:6.0.1.1.13.0.1.16SECTION 524.900
     524.900 Famphur.
21:6.0.1.1.13.0.1.17SECTION 524.920
     524.920 Fenthion.
21:6.0.1.1.13.0.1.18SECTION 524.955
     524.955 Florfenicol, terbinafine, and betamethasone acetate otic gel.
21:6.0.1.1.13.0.1.19SECTION 524.957
     524.957 Florfenicol, terbinafine, and mometasone otic solution.
21:6.0.1.1.13.0.1.20SECTION 524.960
     524.960 Flumethasone, neomycin, and polymyxin B ophthalmic solution.
21:6.0.1.1.13.0.1.21SECTION 524.970
     524.970 Flunixin.
21:6.0.1.1.13.0.1.22SECTION 524.981
     524.981 [Reserved]
21:6.0.1.1.13.0.1.23SECTION 524.981a
     524.981a Fluocinolone cream.
21:6.0.1.1.13.0.1.24SECTION 524.981b
     524.981b Fluocinolone solution.
21:6.0.1.1.13.0.1.25SECTION 524.981c
     524.981c Fluocinolone and neomycin cream.
21:6.0.1.1.13.0.1.26SECTION 524.981d
     524.981d Fluocinolone and dimethyl sulfoxide solution.
21:6.0.1.1.13.0.1.27SECTION 524.981e
     524.981e Fluocinolone and dimethyl sulfoxide otic solution.
21:6.0.1.1.13.0.1.28SECTION 524.998
     524.998 Fluralaner.
21:6.0.1.1.13.0.1.29SECTION 524.1001
     524.1001 Furalaner and moxidectin.
21:6.0.1.1.13.0.1.30SECTION 524.1005
     524.1005 Furazolidone powder.
21:6.0.1.1.13.0.1.31SECTION 524.1044
     524.1044 Gentamicin ophthalmic and topical dosage forms.
21:6.0.1.1.13.0.1.32SECTION 524.1044a
     524.1044a Gentamicin ophthalmic solution.
21:6.0.1.1.13.0.1.33SECTION 524.1044b
     524.1044b Gentamicin and betamethasone otic solution.
21:6.0.1.1.13.0.1.34SECTION 524.1044c
     524.1044c Gentamicin ophthalmic ointment.
21:6.0.1.1.13.0.1.35SECTION 524.1044d
     524.1044d Gentamicin and betamethasone ointment.
21:6.0.1.1.13.0.1.36SECTION 524.1044e
     524.1044e Gentamicin spray.
21:6.0.1.1.13.0.1.37SECTION 524.1044f
     524.1044f Gentamicin and betamethasone spray.
21:6.0.1.1.13.0.1.38SECTION 524.1044g
     524.1044g Gentamicin, betamethasone, and clotrimazole ointment.
21:6.0.1.1.13.0.1.39SECTION 524.1044h
     524.1044h Gentamicin, mometasone, and clotrimazole otic suspension.
21:6.0.1.1.13.0.1.40SECTION 524.1044i
     524.1044i Gentamicin and betamethasone ophthalmic solution.
21:6.0.1.1.13.0.1.41SECTION 524.1132
     524.1132 Hydrocortisone, miconazole, and gentamicin otic suspension.
21:6.0.1.1.13.0.1.42SECTION 524.1140
     524.1140 Imidacloprid and ivermectin.
21:6.0.1.1.13.0.1.43SECTION 524.1146
     524.1146 Imidacloprid and moxidectin.
21:6.0.1.1.13.0.1.44SECTION 524.1193
     524.1193 Ivermectin topical solution.
21:6.0.1.1.13.0.1.45SECTION 524.1195
     524.1195 Ivermectin otic suspension.
21:6.0.1.1.13.0.1.46SECTION 524.1200
     524.1200 Kanamycin ophthalmic and topical dosage forms.
21:6.0.1.1.13.0.1.47SECTION 524.1200a
     524.1200a Kanamycin ophthalmic ointment.
21:6.0.1.1.13.0.1.48SECTION 524.1200b
     524.1200b Kanamycin ophthalmic solution.
21:6.0.1.1.13.0.1.49SECTION 524.1204
     524.1204 Kanamycin, amphomycin, and hydrocortisone ointment.
21:6.0.1.1.13.0.1.50SECTION 524.1240
     524.1240 Levamisole.
21:6.0.1.1.13.0.1.51SECTION 524.1376
     524.1376 2-Mercaptobenzothiazole solution.
21:6.0.1.1.13.0.1.52SECTION 524.1443
     524.1443 Miconazole.
21:6.0.1.1.13.0.1.53SECTION 524.1445
     524.1445 Miconazole, polymixin B, and prednisolone suspension.
21:6.0.1.1.13.0.1.54SECTION 524.1446
     524.1446 Milbemycin otic solution.
21:6.0.1.1.13.0.1.55SECTION 524.1448
     524.1448 Mirtazapine transdermal ointment.
21:6.0.1.1.13.0.1.56SECTION 524.1450
     524.1450 Moxidectin.
21:6.0.1.1.13.0.1.57SECTION 524.1465
     524.1465 Mupirocin.
21:6.0.1.1.13.0.1.58SECTION 524.1484
     524.1484 Neomycin ophthalmic and topical dosage forms.
21:6.0.1.1.13.0.1.59SECTION 524.1484b
     524.1484b Neomycin, isoflupredone, tetracaine, and myristyl-gamma-picolinium powder.
21:6.0.1.1.13.0.1.60SECTION 524.1484c
     524.1484c Neomycin, isoflupredone, and tetracaine ointment.
21:6.0.1.1.13.0.1.61SECTION 524.1484d
     524.1484d Neomycin, hydrocortisone, and tetracaine otic ointment.
21:6.0.1.1.13.0.1.62SECTION 524.1484e
     524.1484e Neomycin and polymyxin B ophthalmic solution.
21:6.0.1.1.13.0.1.63SECTION 524.1484f
     524.1484f Neomycin, prednisolone, and tetracaine otic suspension.
21:6.0.1.1.13.0.1.64SECTION 524.1484g
     524.1484g Neomycin, thiabendazole, and dexamethasone solution.
21:6.0.1.1.13.0.1.65SECTION 524.1484h
     524.1484h Neomycin, penicillin, polymyxin B, and hydrocortisone suspension.
21:6.0.1.1.13.0.1.66SECTION 524.1484i
     524.1484i Neomycin and hydrocortisone ointment.
21:6.0.1.1.13.0.1.67SECTION 524.1484j
     524.1484j Neomycin and prednisolone ophthalmic ointment.
21:6.0.1.1.13.0.1.68SECTION 524.1484k
     524.1484k Neomycin and prednisolone suspension.
21:6.0.1.1.13.0.1.69SECTION 524.1580
     524.1580 Nitrofurazone topical dosage forms.
21:6.0.1.1.13.0.1.70SECTION 524.1580a
     524.1580a Nitrofurazone ointment.
21:6.0.1.1.13.0.1.71SECTION 524.1580b
     524.1580b Nitrofurazone soluble powder.
21:6.0.1.1.13.0.1.72SECTION 524.1580c
     524.1580c Nitrofurazone and butacaine ointment.
21:6.0.1.1.13.0.1.73SECTION 524.1600
     524.1600 Nystatin ophthalmic and topical dosage forms.
21:6.0.1.1.13.0.1.74SECTION 524.1600a
     524.1600a Nystatin, neomycin, thiostrepton, and triamcinolone ointment.
21:6.0.1.1.13.0.1.75SECTION 524.1600b
     524.1600b Nystatin, neomycin, thiostrepton, and triamcinolone ophthalmic ointment.
21:6.0.1.1.13.0.1.76SECTION 524.1610
     524.1610 Orbifloxacin, mometasone furoate monohydrate, and posaconazole suspension.
21:6.0.1.1.13.0.1.77SECTION 524.1662
     524.1662 Oxytetracycline ophthalmic and topical dosage forms.
21:6.0.1.1.13.0.1.78SECTION 524.1662a
     524.1662a Oxytetracycline and hydrocortisone spray.
21:6.0.1.1.13.0.1.79SECTION 524.1662b
     524.1662b Oxytetracycline and polymyxin B ophthalmic ointment.
21:6.0.1.1.13.0.1.80SECTION 524.1742
     524.1742 Phosmet emulsifiable liquid.
21:6.0.1.1.13.0.1.81SECTION 524.1982
     524.1982 Proparacaine ophthalmic solution.
21:6.0.1.1.13.0.1.82SECTION 524.2098
     524.2098 Selamectin.
21:6.0.1.1.13.0.1.83SECTION 524.2099
     524.2099 Selamectin and sarolaner.
21:6.0.1.1.13.0.1.84SECTION 524.2101
     524.2101 Selenium disulfide suspension.
21:6.0.1.1.13.0.1.85SECTION 524.2350
     524.2350 Tolnaftate cream.
21:6.0.1.1.13.0.1.86SECTION 524.2482
     524.2482 Triamcinolone spray.
21:6.0.1.1.13.0.1.87SECTION 524.2483
     524.2483 Triamcinolone cream.
21:6.0.1.1.13.0.1.88SECTION 524.2620
     524.2620 Liquid crystalline trypsin, Peru balsam, castor oil.
21:6.0.1.1.14PART 526
PART 526 - INTRAMAMMARY DOSAGE FORM NEW ANIMAL DRUGS
21:6.0.1.1.14.0.2.1SECTION 526.88
     526.88 Amoxicillin trihydrate for intramammary infusion.
21:6.0.1.1.14.0.2.2SECTION 526.313
     526.313 Ceftiofur.
21:6.0.1.1.14.0.2.3SECTION 526.363
     526.363 Cephapirin benzathine.
21:6.0.1.1.14.0.2.4SECTION 526.365
     526.365 Cephapirin sodium.
21:6.0.1.1.14.0.2.5SECTION 526.464
     526.464 Cloxacillin intramammary dosage forms.
21:6.0.1.1.14.0.2.6SECTION 526.464a
     526.464a Cloxacillin benzathine.
21:6.0.1.1.14.0.2.7SECTION 526.464b
     526.464b Cloxacillin sodium for intramammary infusion, sterile.
21:6.0.1.1.14.0.2.8SECTION 526.820
     526.820 Erythromycin.
21:6.0.1.1.14.0.2.9SECTION 526.1130
     526.1130 Hetacillin.
21:6.0.1.1.14.0.2.10SECTION 526.1590
     526.1590 Novobiocin infusion.
21:6.0.1.1.14.0.2.11SECTION 526.1696
     526.1696 Penicillin intramammary dosage forms.
21:6.0.1.1.14.0.2.12SECTION 526.1696a
     526.1696a Penicillin G procaine.
21:6.0.1.1.14.0.2.13SECTION 526.1696b
     526.1696b Penicillin G procaine-dihydrostreptomycin in soybean oil for intramammary infusion (dry cows).
21:6.0.1.1.14.0.2.14SECTION 526.1696c
     526.1696c Penicillin G procaine-dihydrostreptomycin sulfate for intramammary infusion (dry cows).
21:6.0.1.1.14.0.2.15SECTION 526.1696d
     526.1696d Penicillin G procaine-novobiocin for intramammary infusion.
21:6.0.1.1.14.0.2.16SECTION 526.1810
     526.1810 Pirlimycin.
21:6.0.1.1.15PART 528
PART 528 - NEW ANIMAL DRUGS IN GENETICALLY ENGINEERED ANIMALS
21:6.0.1.1.15.0.2.1SECTION 528.1070
     528.1070 Bc6 recombinant deoxyribonucleic acid construct.
21:6.0.1.1.15.0.2.2SECTION 528.1080
     528.1080 Bc2371 recombinant deoxyribonucleic acid construct.
21:6.0.1.1.15.0.2.3SECTION 528.1092
     528.1092 opAFP-GHc2 recombinant deoxyribonucleic acid construct.
21:6.0.1.1.15.0.2.4SECTION 528.2010
     528.2010 Human lysosomal acid lipase recombinant deoxyribonucleic acid construct.
21:6.0.1.1.16PART 529
PART 529 - CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS
21:6.0.1.1.16.0.2.1SECTION 529.40
     529.40 Albuterol.
21:6.0.1.1.16.0.2.2SECTION 529.56
     529.56 Amikacin.
21:6.0.1.1.16.0.2.3SECTION 529.382
     529.382 Chloramine-T.
21:6.0.1.1.16.0.2.4SECTION 529.400
     529.400 Chlorhexidine tablets and suspension.
21:6.0.1.1.16.0.2.5SECTION 529.536
     529.536 Detomidine.
21:6.0.1.1.16.0.2.6SECTION 529.539
     529.539 Dexmedetomidine.
21:6.0.1.1.16.0.2.7SECTION 529.778
     529.778 Doxycycline.
21:6.0.1.1.16.0.2.8SECTION 529.1030
     529.1030 Formalin.
21:6.0.1.1.16.0.2.9SECTION 529.1044
     529.1044 Gentamicin in certain other dosage forms.
21:6.0.1.1.16.0.2.10SECTION 529.1044a
     529.1044a Gentamicin solution for infusion.
21:6.0.1.1.16.0.2.11SECTION 529.1044b
     529.1044b Gentamicin solution for dipping eggs.
21:6.0.1.1.16.0.2.12SECTION 529.1115
     529.1115 Halothane.
21:6.0.1.1.16.0.2.13SECTION 529.1150
     529.1150 Hydrogen peroxide.
21:6.0.1.1.16.0.2.14SECTION 529.1186
     529.1186 Isoflurane.
21:6.0.1.1.16.0.2.15SECTION 529.1350
     529.1350 Meloxicam.
21:6.0.1.1.16.0.2.16SECTION 529.1660
     529.1660 Oxytetracycline.
21:6.0.1.1.16.0.2.17SECTION 529.1940
     529.1940 Progesterone intravaginal inserts.
21:6.0.1.1.16.0.2.18SECTION 529.2150
     529.2150 Sevoflurane.
21:6.0.1.1.16.0.2.19SECTION 529.2464
     529.2464 Ticarcillin.
21:6.0.1.1.16.0.2.20SECTION 529.2503
     529.2503 Tricaine methanesulfonate.
21:6.0.1.1.16.0.2.21SECTION 529.2620
     529.2620 Triptorelin.
21:6.0.1.1.17PART 530
PART 530 - EXTRALABEL DRUG USE IN ANIMALS
21:6.0.1.1.17.1SUBPART A
Subpart A - General Provisions
21:6.0.1.1.17.1.2.1SECTION 530.1
     530.1 Scope.
21:6.0.1.1.17.1.2.2SECTION 530.2
     530.2 Purpose.
21:6.0.1.1.17.1.2.3SECTION 530.3
     530.3 Definitions.
21:6.0.1.1.17.1.2.4SECTION 530.4
     530.4 Advertising and promotion.
21:6.0.1.1.17.1.2.5SECTION 530.5
     530.5 Veterinary records.
21:6.0.1.1.17.2SUBPART B
Subpart B - Rules and Provisions for Extralabel Uses of Drugs in Animals
21:6.0.1.1.17.2.2.1SECTION 530.10
     530.10 Provision permitting extralabel use of animal drugs.
21:6.0.1.1.17.2.2.2SECTION 530.11
     530.11 Limitations.
21:6.0.1.1.17.2.2.3SECTION 530.12
     530.12 Labeling.
21:6.0.1.1.17.2.2.4SECTION 530.13
     530.13 Extralabel use from compounding of approved new animal and approved human drugs.
21:6.0.1.1.17.3SUBPART C
Subpart C - Specific Provisions Relating to Extralabel Use of Animal and Human Drugs in Food-Producing Animals
21:6.0.1.1.17.3.2.1SECTION 530.20
     530.20 Conditions for permitted extralabel animal and human drug use in food-producing animals.
21:6.0.1.1.17.3.2.2SECTION 530.21
     530.21 Prohibitions for food-producing animals.
21:6.0.1.1.17.3.2.3SECTION 530.22
     530.22 Safe levels and analytical methods for food-producing animals.
21:6.0.1.1.17.3.2.4SECTION 530.23
     530.23 Procedure for setting and announcing safe levels.
21:6.0.1.1.17.3.2.5SECTION 530.24
     530.24 Procedure for announcing analytical methods for drug residue quantification.
21:6.0.1.1.17.3.2.6SECTION 530.25
     530.25 Orders prohibiting extralabel uses for drugs in food-producing animals.
21:6.0.1.1.17.4SUBPART D
Subpart D - Extralabel Use of Human and Animal Drugs in Animals Not Intended for Human Consumption
21:6.0.1.1.17.4.2.1SECTION 530.30
     530.30 Extralabel drug use in nonfood animals.
21:6.0.1.1.17.5SUBPART E
Subpart E - Safe Levels for Extralabel Use of Drugs in Animals and Drugs Prohibited From Extralabel Use in Animals
21:6.0.1.1.17.5.2.1SECTION 530.40
     530.40 Safe levels and availability of analytical methods.
21:6.0.1.1.17.5.2.2SECTION 530.41
     530.41 Drugs prohibited for extralabel use in animals.
21:6.0.1.1.18PART 556
PART 556 - TOLERANCES FOR RESIDUES OF NEW ANIMAL DRUGS IN FOOD
21:6.0.1.1.18.1SUBPART A
Subpart A - General Provisions
21:6.0.1.1.18.1.2.1SECTION 556.1
     556.1 Scope.
21:6.0.1.1.18.1.2.2SECTION 556.3
     556.3 Definitions.
21:6.0.1.1.18.1.2.3SECTION 556.5
     556.5 General considerations.
21:6.0.1.1.18.2SUBPART B
Subpart B - Specific Tolerances for Residues of Approved and Conditionally Approved New Animal Drugs
21:6.0.1.1.18.2.2.1SECTION 556.34
     556.34 Albendazole.
21:6.0.1.1.18.2.2.2SECTION 556.36
     556.36 Altrenogest.
21:6.0.1.1.18.2.2.3SECTION 556.38
     556.38 Amoxicillin.
21:6.0.1.1.18.2.2.4SECTION 556.40
     556.40 Ampicillin.
21:6.0.1.1.18.2.2.5SECTION 556.50
     556.50 Amprolium.
21:6.0.1.1.18.2.2.6SECTION 556.52
     556.52 Apramycin.
21:6.0.1.1.18.2.2.7SECTION 556.60
     556.60 Avilamycin.
21:6.0.1.1.18.2.2.8SECTION 556.68
     556.68 Azaperone.
21:6.0.1.1.18.2.2.9SECTION 556.70
     556.70 Bacitracin.
21:6.0.1.1.18.2.2.10SECTION 556.75
     556.75 Bambermycins.
21:6.0.1.1.18.2.2.11SECTION 556.100
     556.100 Carbadox.
21:6.0.1.1.18.2.2.12SECTION 556.110
     556.110 Carbomycin.
21:6.0.1.1.18.2.2.13SECTION 556.113
     556.113 Ceftiofur.
21:6.0.1.1.18.2.2.14SECTION 556.115
     556.115 Cephapirin.
21:6.0.1.1.18.2.2.15SECTION 556.118
     556.118 Chloramine-T.
21:6.0.1.1.18.2.2.16SECTION 556.120
     556.120 Chlorhexidine.
21:6.0.1.1.18.2.2.17SECTION 556.150
     556.150 Chlortetracycline.
21:6.0.1.1.18.2.2.18SECTION 556.160
     556.160 Clopidol.
21:6.0.1.1.18.2.2.19SECTION 556.163
     556.163 Clorsulon.
21:6.0.1.1.18.2.2.20SECTION 556.165
     556.165 Cloxacillin.
21:6.0.1.1.18.2.2.21SECTION 556.167
     556.167 Colistimethate.
21:6.0.1.1.18.2.2.22SECTION 556.169
     556.169 Danofloxacin.
21:6.0.1.1.18.2.2.23SECTION 556.170
     556.170 Decoquinate.
21:6.0.1.1.18.2.2.24SECTION 556.180
     556.180 Dichlorvos.
21:6.0.1.1.18.2.2.25SECTION 556.185
     556.185 Diclazuril.
21:6.0.1.1.18.2.2.26SECTION 556.200
     556.200 Dihydrostreptomycin.
21:6.0.1.1.18.2.2.27SECTION 556.222
     556.222 Doramectin.
21:6.0.1.1.18.2.2.28SECTION 556.224
     556.224 Efrotomycin.
21:6.0.1.1.18.2.2.29SECTION 556.226
     556.226 Enrofloxacin.
21:6.0.1.1.18.2.2.30SECTION 556.227
     556.227 Eprinomectin.
21:6.0.1.1.18.2.2.31SECTION 556.230
     556.230 Erythromycin.
21:6.0.1.1.18.2.2.32SECTION 556.240
     556.240 Estradiol and related esters.
21:6.0.1.1.18.2.2.33SECTION 556.260
     556.260 Ethopabate.
21:6.0.1.1.18.2.2.34SECTION 556.273
     556.273 Famphur.
21:6.0.1.1.18.2.2.35SECTION 556.275
     556.275 Fenbendazole.
21:6.0.1.1.18.2.2.36SECTION 556.277
     556.277 Fenprostalene.
21:6.0.1.1.18.2.2.37SECTION 556.280
     556.280 Fenthion.
21:6.0.1.1.18.2.2.38SECTION 556.283
     556.283 Florfenicol.
21:6.0.1.1.18.2.2.39SECTION 556.286
     556.286 Flunixin.
21:6.0.1.1.18.2.2.40SECTION 556.292
     556.292 Gamithromycin.
21:6.0.1.1.18.2.2.41SECTION 556.300
     556.300 Gentamicin.
21:6.0.1.1.18.2.2.42SECTION 556.304
     556.304 Gonadotropin.
21:6.0.1.1.18.2.2.43SECTION 556.308
     556.308 Halofuginone.
21:6.0.1.1.18.2.2.44SECTION 556.310
     556.310 Haloxon.
21:6.0.1.1.18.2.2.45SECTION 556.316
     556.316 Hetacillin.
21:6.0.1.1.18.2.2.46SECTION 556.330
     556.330 Hygromycin B.
21:6.0.1.1.18.2.2.47SECTION 556.344
     556.344 Ivermectin.
21:6.0.1.1.18.2.2.48SECTION 556.346
     556.346 Laidlomycin.
21:6.0.1.1.18.2.2.49SECTION 556.347
     556.347 Lasalocid.
21:6.0.1.1.18.2.2.50SECTION 556.350
     556.350 Levamisole.
21:6.0.1.1.18.2.2.51SECTION 556.360
     556.360 Lincomycin.
21:6.0.1.1.18.2.2.52SECTION 556.370
     556.370 Lubabegron.
21:6.0.1.1.18.2.2.53SECTION 556.375
     556.375 Maduramicin.
21:6.0.1.1.18.2.2.54SECTION 556.380
     556.380 Melengestrol.
21:6.0.1.1.18.2.2.55SECTION 556.410
     556.410 Metoserpate.
21:6.0.1.1.18.2.2.56SECTION 556.420
     556.420 Monensin.
21:6.0.1.1.18.2.2.57SECTION 556.425
     556.425 Morantel.
21:6.0.1.1.18.2.2.58SECTION 556.426
     556.426 Moxidectin.
21:6.0.1.1.18.2.2.59SECTION 556.428
     556.428 Narasin.
21:6.0.1.1.18.2.2.60SECTION 556.430
     556.430 Neomycin.
21:6.0.1.1.18.2.2.61SECTION 556.445
     556.445 Nicarbazin.
21:6.0.1.1.18.2.2.62SECTION 556.460
     556.460 Novobiocin.
21:6.0.1.1.18.2.2.63SECTION 556.470
     556.470 Nystatin.
21:6.0.1.1.18.2.2.64SECTION 556.490
     556.490 Ormetoprim.
21:6.0.1.1.18.2.2.65SECTION 556.495
     556.495 Oxfendazole.
21:6.0.1.1.18.2.2.66SECTION 556.500
     556.500 Oxytetracycline.
21:6.0.1.1.18.2.2.67SECTION 556.510
     556.510 Penicillin.
21:6.0.1.1.18.2.2.68SECTION 556.515
     556.515 Pirlimycin.
21:6.0.1.1.18.2.2.69SECTION 556.517
     556.517 Poloxalene.
21:6.0.1.1.18.2.2.70SECTION 556.540
     556.540 Progesterone.
21:6.0.1.1.18.2.2.71SECTION 556.560
     556.560 Pyrantel.
21:6.0.1.1.18.2.2.72SECTION 556.570
     556.570 Ractopamine.
21:6.0.1.1.18.2.2.73SECTION 556.580
     556.580 Robenidine.
21:6.0.1.1.18.2.2.74SECTION 556.592
     556.592 Salinomycin.
21:6.0.1.1.18.2.2.75SECTION 556.597
     556.597 Semduramicin.
21:6.0.1.1.18.2.2.76SECTION 556.600
     556.600 Spectinomycin.
21:6.0.1.1.18.2.2.77SECTION 556.610
     556.610 Streptomycin.
21:6.0.1.1.18.2.2.78SECTION 556.620
     556.620 Sulfabromomethazine.
21:6.0.1.1.18.2.2.79SECTION 556.625
     556.625 Sulfachloropyrazine.
21:6.0.1.1.18.2.2.80SECTION 556.630
     556.630 Sulfachlorpyridazine.
21:6.0.1.1.18.2.2.81SECTION 556.640
     556.640 Sulfadimethoxine.
21:6.0.1.1.18.2.2.82SECTION 556.650
     556.650 Sulfaethoxypyridazine.
21:6.0.1.1.18.2.2.83SECTION 556.660
     556.660 Sulfamerazine.
21:6.0.1.1.18.2.2.84SECTION 556.670
     556.670 Sulfamethazine.
21:6.0.1.1.18.2.2.85SECTION 556.685
     556.685 Sulfaquinoxaline.
21:6.0.1.1.18.2.2.86SECTION 556.700
     556.700 Sulfomyxin.
21:6.0.1.1.18.2.2.87SECTION 556.710
     556.710 Testosterone.
21:6.0.1.1.18.2.2.88SECTION 556.720
     556.720 Tetracycline.
21:6.0.1.1.18.2.2.89SECTION 556.730
     556.730 Thiabendazole.
21:6.0.1.1.18.2.2.90SECTION 556.732
     556.732 Tiamulin.
21:6.0.1.1.18.2.2.91SECTION 556.733
     556.733 Tildipirosin.
21:6.0.1.1.18.2.2.92SECTION 556.735
     556.735 Tilmicosin.
21:6.0.1.1.18.2.2.93SECTION 556.739
     556.739 Trenbolone.
21:6.0.1.1.18.2.2.94SECTION 556.741
     556.741 Tripelennamine.
21:6.0.1.1.18.2.2.95SECTION 556.745
     556.745 Tulathromycin.
21:6.0.1.1.18.2.2.96SECTION 556.746
     556.746 Tylosin.
21:6.0.1.1.18.2.2.97SECTION 556.748
     556.748 Tylvalosin.
21:6.0.1.1.18.2.2.98SECTION 556.750
     556.750 Virginiamycin.
21:6.0.1.1.18.2.2.99SECTION 556.760
     556.760 Zeranol.
21:6.0.1.1.18.2.2.100SECTION 556.765
     556.765 Zilpaterol.
21:6.0.1.1.18.2.2.101SECTION 556.770
     556.770 Zoalene.
21:6.0.1.1.19PART 558
PART 558 - NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS
21:6.0.1.1.19.1SUBPART A
Subpart A - General Provisions
21:6.0.1.1.19.1.2.1SECTION 558.3
     558.3 Definitions and general considerations applicable to this part.
21:6.0.1.1.19.1.2.2SECTION 558.4
     558.4 Requirement of a medicated feed mill license.
21:6.0.1.1.19.1.2.3SECTION 558.5
     558.5 Requirements for liquid medicated feed.
21:6.0.1.1.19.1.2.4SECTION 558.6
     558.6 Veterinary feed directive drugs.
21:6.0.1.1.19.2SUBPART B
Subpart B - Specific New Animal Drugs for Use in Animal Feeds
21:6.0.1.1.19.2.2.1SECTION 558.55
     558.55 Amprolium.
21:6.0.1.1.19.2.2.2SECTION 558.58
     558.58 Amprolium and ethopabate.
21:6.0.1.1.19.2.2.3SECTION 558.59
     558.59 Apramycin.
21:6.0.1.1.19.2.2.4SECTION 558.68
     558.68 Avilamycin.
21:6.0.1.1.19.2.2.5SECTION 558.76
     558.76 Bacitracin methylenedisalicylate.
21:6.0.1.1.19.2.2.6SECTION 558.78
     558.78 Bacitracin zinc.
21:6.0.1.1.19.2.2.7SECTION 558.95
     558.95 Bambermycins.
21:6.0.1.1.19.2.2.8SECTION 558.115
     558.115 Carbadox.
21:6.0.1.1.19.2.2.9SECTION 558.128
     558.128 Chlortetracycline.
21:6.0.1.1.19.2.2.10SECTION 558.140
     558.140 Chlortetracycline and sulfamethazine.
21:6.0.1.1.19.2.2.11SECTION 558.175
     558.175 Clopidol.
21:6.0.1.1.19.2.2.12SECTION 558.195
     558.195 Decoquinate.
21:6.0.1.1.19.2.2.13SECTION 558.198
     558.198 Dichlorvos.
21:6.0.1.1.19.2.2.14SECTION 558.205
     558.205 Diclazuril.
21:6.0.1.1.19.2.2.15SECTION 558.235
     558.235 Efrotomycin.
21:6.0.1.1.19.2.2.16SECTION 558.248
     558.248 Erythromycin.
21:6.0.1.1.19.2.2.17SECTION 558.254
     558.254 Famphur.
21:6.0.1.1.19.2.2.18SECTION 558.258
     558.258 Fenbendazole.
21:6.0.1.1.19.2.2.19SECTION 558.261
     558.261 Florfenicol.
21:6.0.1.1.19.2.2.20SECTION 558.265
     558.265 Halofuginone.
21:6.0.1.1.19.2.2.21SECTION 558.274
     558.274 Hygromycin B.
21:6.0.1.1.19.2.2.22SECTION 558.295
     558.295 Iodinated casein.
21:6.0.1.1.19.2.2.23SECTION 558.300
     558.300 Ivermectin.
21:6.0.1.1.19.2.2.24SECTION 558.305
     558.305 Laidlomycin.
21:6.0.1.1.19.2.2.25SECTION 558.311
     558.311 Lasalocid.
21:6.0.1.1.19.2.2.26SECTION 558.325
     558.325 Lincomycin.
21:6.0.1.1.19.2.2.27SECTION 558.330
     558.330 Lubabegron.
21:6.0.1.1.19.2.2.28SECTION 558.340
     558.340 Maduramicin.
21:6.0.1.1.19.2.2.29SECTION 558.342
     558.342 Melengestrol.
21:6.0.1.1.19.2.2.30SECTION 558.348
     558.348 Mibolerone.
21:6.0.1.1.19.2.2.31SECTION 558.355
     558.355 Monensin.
21:6.0.1.1.19.2.2.32SECTION 558.360
     558.360 Morantel.
21:6.0.1.1.19.2.2.33SECTION 558.363
     558.363 Narasin.
21:6.0.1.1.19.2.2.34SECTION 558.364
     558.364 Narasin and nicarbazin.
21:6.0.1.1.19.2.2.35SECTION 558.365
     558.365 Neomycin sulfate.
21:6.0.1.1.19.2.2.36SECTION 558.366
     558.366 Nicarbazin.
21:6.0.1.1.19.2.2.37SECTION 558.415
     558.415 Novobiocin.
21:6.0.1.1.19.2.2.38SECTION 558.430
     558.430 Nystatin.
21:6.0.1.1.19.2.2.39SECTION 558.450
     558.450 Oxytetracycline.
21:6.0.1.1.19.2.2.40SECTION 558.455
     558.455 Oxytetracycline and neomycin.
21:6.0.1.1.19.2.2.41SECTION 558.464
     558.464 Poloxalene.
21:6.0.1.1.19.2.2.42SECTION 558.465
     558.465 Poloxalene free-choice liquid Type C feed.
21:6.0.1.1.19.2.2.43SECTION 558.485
     558.485 Pyrantel.
21:6.0.1.1.19.2.2.44SECTION 558.500
     558.500 Ractopamine.
21:6.0.1.1.19.2.2.45SECTION 558.515
     558.515 Robenidine.
21:6.0.1.1.19.2.2.46SECTION 558.550
     558.550 Salinomycin.
21:6.0.1.1.19.2.2.47SECTION 558.555
     558.555 Semduramicin.
21:6.0.1.1.19.2.2.48SECTION 558.575
     558.575 Sulfadimethoxine and ormetoprim.
21:6.0.1.1.19.2.2.49SECTION 558.582
     558.582 Sulfamerazine.
21:6.0.1.1.19.2.2.50SECTION 558.586
     558.586 Sulfaquinoxaline.
21:6.0.1.1.19.2.2.51SECTION 558.600
     558.600 Thiabendazole.
21:6.0.1.1.19.2.2.52SECTION 558.612
     558.612 Tiamulin.
21:6.0.1.1.19.2.2.53SECTION 558.618
     558.618 Tilmicosin.
21:6.0.1.1.19.2.2.54SECTION 558.625
     558.625 Tylosin.
21:6.0.1.1.19.2.2.55SECTION 558.630
     558.630 Tylosin and sulfamethazine.
21:6.0.1.1.19.2.2.56SECTION 558.633
     558.633 Tylvalosin.
21:6.0.1.1.19.2.2.57SECTION 558.635
     558.635 Virginiamycin.
21:6.0.1.1.19.2.2.58SECTION 558.665
     558.665 Zilpaterol.
21:6.0.1.1.19.2.2.59SECTION 558.680
     558.680 Zoalene.
21:6.0.1.1.20PART 564
PART 564 [RESERVED]
21:6.0.1.1.21PART 570
PART 570 - FOOD ADDITIVES
21:6.0.1.1.21.1SUBPART A
Subpart A - General Provisions
21:6.0.1.1.21.1.2.1SECTION 570.3
     570.3 Definitions.
21:6.0.1.1.21.1.2.2SECTION 570.6
     570.6 Opinion letters on food additive status.
21:6.0.1.1.21.1.2.3SECTION 570.13
     570.13 Indirect food additives resulting from packaging materials prior sanctioned for animal feed and pet food.
21:6.0.1.1.21.1.2.4SECTION 570.14
     570.14 Indirect food additives resulting from packaging materials for animal feed and pet food.
21:6.0.1.1.21.1.2.5SECTION 570.15
     570.15 Adoption of regulation on initiative of Commissioner.
21:6.0.1.1.21.1.2.6SECTION 570.17
     570.17 Exemption for investigational use and procedure for obtaining authorization to market edible products from experimental animals.
21:6.0.1.1.21.1.2.7SECTION 570.18
     570.18 Tolerances for related food additives.
21:6.0.1.1.21.1.2.8SECTION 570.19
     570.19 Pesticide chemicals in processed foods.
21:6.0.1.1.21.2SUBPART B
Subpart B - Food Additive Safety
21:6.0.1.1.21.2.2.1SECTION 570.20
     570.20 General principles for evaluating the safety of food additives.
21:6.0.1.1.21.2.2.2SECTION 570.30
     570.30 Eligibility for classification as generally recognized as safe (GRAS).
21:6.0.1.1.21.2.2.3SECTION 570.35
     570.35 Affirmation of generally recognized as safe (GRAS) status.
21:6.0.1.1.21.2.2.4SECTION 570.38
     570.38 Determination of food additive status.
21:6.0.1.1.21.3SUBPART C
Subparts C-D [Reserved]
21:6.0.1.1.21.4SUBPART E
Subpart E - Generally Recognized as Safe (GRAS) Notice
21:6.0.1.1.21.4.2.1SECTION 570.203
     570.203 Definitions.
21:6.0.1.1.21.4.2.2SECTION 570.205
     570.205 Opportunity to submit a GRAS notice.
21:6.0.1.1.21.4.2.3SECTION 570.210
     570.210 How to send your GRAS notice to FDA.
21:6.0.1.1.21.4.2.4SECTION 570.215
     570.215 Incorporation into a GRAS notice.
21:6.0.1.1.21.4.2.5SECTION 570.220
     570.220 General requirements applicable to a GRAS notice.
21:6.0.1.1.21.4.2.6SECTION 570.225
     570.225 Part 1 of a GRAS notice: Signed statements and certification.
21:6.0.1.1.21.4.2.7SECTION 570.230
     570.230 Part 2 of a GRAS notice: Identity, method of manufacture, specifications, and physical or technical effect.
21:6.0.1.1.21.4.2.8SECTION 570.235
     570.235 Part 3 of a GRAS notice: Target animal and human exposures.
21:6.0.1.1.21.4.2.9SECTION 570.240
     570.240 Part 4 of a GRAS notice: Self-limiting levels of use.
21:6.0.1.1.21.4.2.10SECTION 570.245
     570.245 Part 5 of a GRAS notice: Experience based on common use in food before 1958.
21:6.0.1.1.21.4.2.11SECTION 570.250
     570.250 Part 6 of a GRAS notice: Narrative.
21:6.0.1.1.21.4.2.12SECTION 570.255
     570.255 Part 7 of a GRAS notice: List of supporting data and information in your GRAS notice.
21:6.0.1.1.21.4.2.13SECTION 570.260
     570.260 Steps you may take before FDA responds to your GRAS notice.
21:6.0.1.1.21.4.2.14SECTION 570.265
     570.265 What FDA will do with a GRAS notice.
21:6.0.1.1.21.4.2.15SECTION 570.275
     570.275 Public disclosure of a GRAS notice.
21:6.0.1.1.21.4.2.16SECTION 570.280
     570.280 Submission of a supplement.
21:6.0.1.1.22PART 571
PART 571 - FOOD ADDITIVE PETITIONS
21:6.0.1.1.22.1SUBPART A
Subpart A - General Provisions
21:6.0.1.1.22.1.2.1SECTION 571.1
     571.1 Petitions.
21:6.0.1.1.22.1.2.2SECTION 571.6
     571.6 Amendment of petition.
21:6.0.1.1.22.1.2.3SECTION 571.7
     571.7 Withdrawal of petition without prejudice.
21:6.0.1.1.22.2SUBPART B
Subpart B - Administrative Actions on Applications
21:6.0.1.1.22.2.2.1SECTION 571.100
     571.100 Regulation based on petition.
21:6.0.1.1.22.2.2.2SECTION 571.102
     571.102 Effective date of regulation.
21:6.0.1.1.22.2.2.3SECTION 571.110
     571.110 Procedure for objections and hearings.
21:6.0.1.1.22.2.2.4SECTION 571.115
     571.115 Application of the cancer clause of section 409 of the act.
21:6.0.1.1.22.2.2.5SECTION 571.130
     571.130 Procedure for amending and repealing tolerances or exemptions from tolerances.
21:6.0.1.1.23PART 573
PART 573 - FOOD ADDITIVES PERMITTED IN FEED AND DRINKING WATER OF ANIMALS
21:6.0.1.1.23.1SUBPART A
Subpart A [Reserved]
21:6.0.1.1.23.2SUBPART B
Subpart B - Food Additive Listing
21:6.0.1.1.23.2.2.1SECTION 573.120
     573.120 Acrylamide-acrylic acid resin.
21:6.0.1.1.23.2.2.2SECTION 573.130
     573.130 Aminoglycoside 3′-phospho- transferase II.
21:6.0.1.1.23.2.2.3SECTION 573.140
     573.140 Ammoniated cottonseed meal.
21:6.0.1.1.23.2.2.4SECTION 573.160
     573.160 Ammoniated rice hulls.
21:6.0.1.1.23.2.2.5SECTION 573.170
     573.170 Ammonium formate.
21:6.0.1.1.23.2.2.6SECTION 573.180
     573.180 Anhydrous ammonia.
21:6.0.1.1.23.2.2.7SECTION 573.200
     573.200 Condensed animal protein hydrolysate.
21:6.0.1.1.23.2.2.8SECTION 573.210
     573.210 Benzoic acid.
21:6.0.1.1.23.2.2.9SECTION 573.220
     573.220 Feed-grade biuret.
21:6.0.1.1.23.2.2.10SECTION 573.225
     573.225 1,3-Butylene glycol.
21:6.0.1.1.23.2.2.11SECTION 573.240
     573.240 Calcium periodate.
21:6.0.1.1.23.2.2.12SECTION 573.260
     573.260 Calcium silicate.
21:6.0.1.1.23.2.2.13SECTION 573.280
     573.280 Feed-grade calcium stearate and sodium stearate.
21:6.0.1.1.23.2.2.14SECTION 573.300
     573.300 Choline xanthate.
21:6.0.1.1.23.2.2.15SECTION 573.304
     573.304 Chromium Propionate.
21:6.0.1.1.23.2.2.16SECTION 573.310
     573.310 Crambe meal, heat toasted.
21:6.0.1.1.23.2.2.17SECTION 573.320
     573.320 Diammonium phosphate.
21:6.0.1.1.23.2.2.18SECTION 573.340
     573.340 Diatomaceous earth.
21:6.0.1.1.23.2.2.19SECTION 573.360
     573.360 Disodium EDTA.
21:6.0.1.1.23.2.2.20SECTION 573.380
     573.380 Ethoxyquin in animal feeds.
21:6.0.1.1.23.2.2.21SECTION 573.400
     573.400 Ethoxyquin in certain dehydrated forage crops.
21:6.0.1.1.23.2.2.22SECTION 573.420
     573.420 Ethyl cellulose.
21:6.0.1.1.23.2.2.23SECTION 573.440
     573.440 Ethylene dichloride.
21:6.0.1.1.23.2.2.24SECTION 573.450
     573.450 Fermented ammoniated condensed whey.
21:6.0.1.1.23.2.2.25SECTION 573.460
     573.460 Formaldehyde.
21:6.0.1.1.23.2.2.26SECTION 573.480
     573.480 Formic acid.
21:6.0.1.1.23.2.2.27SECTION 573.490
     573.490 Gamma-linolenic acid safflower meal.
21:6.0.1.1.23.2.2.28SECTION 573.492
     573.492 Gamma-linolenic acid safflower oil.
21:6.0.1.1.23.2.2.29SECTION 573.496
     573.496 Guanidinoacetic acid.
21:6.0.1.1.23.2.2.30SECTION 573.500
     573.500 Condensed, extracted glutamic acid fermentation product.
21:6.0.1.1.23.2.2.31SECTION 573.520
     573.520 Hemicellulose extract.
21:6.0.1.1.23.2.2.32SECTION 573.530
     573.530 Hydrogenated corn syrup.
21:6.0.1.1.23.2.2.33SECTION 573.540
     573.540 Hydrolyzed leather meal.
21:6.0.1.1.23.2.2.34SECTION 573.550
     573.550 25-hydroxyvitamin D3.
21:6.0.1.1.23.2.2.35SECTION 573.560
     573.560 Iron ammonium citrate.
21:6.0.1.1.23.2.2.36SECTION 573.580
     573.580 Iron-choline citrate complex.
21:6.0.1.1.23.2.2.37SECTION 573.600
     573.600 Lignin sulfonates.
21:6.0.1.1.23.2.2.38SECTION 573.615
     573.615 Marine microalgae.
21:6.0.1.1.23.2.2.39SECTION 573.620
     573.620 Menadione dimethylpyrimidinol bisulfite.
21:6.0.1.1.23.2.2.40SECTION 573.625
     573.625 Menadione nicotinamide bisulfite.
21:6.0.1.1.23.2.2.41SECTION 573.637
     573.637 Methyl esters of conjugated linoleic acid (cis-9, trans-11 and trans-10, cis-12-octadecadienoic acids).
21:6.0.1.1.23.2.2.42SECTION 573.640
     573.640 Methyl esters of higher fatty acids.
21:6.0.1.1.23.2.2.43SECTION 573.660
     573.660 Methyl glucoside-coconut oil ester.
21:6.0.1.1.23.2.2.44SECTION 573.680
     573.680 Mineral oil.
21:6.0.1.1.23.2.2.45SECTION 573.685
     573.685 Natamycin.
21:6.0.1.1.23.2.2.46SECTION 573.696
     573.696 Feed grade sodium formate.
21:6.0.1.1.23.2.2.47SECTION 573.700
     573.700 Sodium nitrite.
21:6.0.1.1.23.2.2.48SECTION 573.720
     573.720 Petrolatum.
21:6.0.1.1.23.2.2.49SECTION 573.740
     573.740 Odorless light petroleum hydrocarbons.
21:6.0.1.1.23.2.2.50SECTION 573.750
     573.750 Pichia pastoris dried yeast.
21:6.0.1.1.23.2.2.51SECTION 573.760
     573.760 Poloxalene.
21:6.0.1.1.23.2.2.52SECTION 573.780
     573.780 Polyethylene.
21:6.0.1.1.23.2.2.53SECTION 573.800
     573.800 Polyethylene glycol (400) mono- and dioleate.
21:6.0.1.1.23.2.2.54SECTION 573.820
     573.820 Polyoxyethylene glycol (400) mono- and dioleates.
21:6.0.1.1.23.2.2.55SECTION 573.840
     573.840 Polysorbate 60.
21:6.0.1.1.23.2.2.56SECTION 573.860
     573.860 Polysorbate 80.
21:6.0.1.1.23.2.2.57SECTION 573.870
     573.870 Poly(2-vinylpyridine-co-styrene).
21:6.0.1.1.23.2.2.58SECTION 573.880
     573.880 Normal propyl alcohol.
21:6.0.1.1.23.2.2.59SECTION 573.900
     573.900 Pyrophyllite.
21:6.0.1.1.23.2.2.60SECTION 573.914
     573.914 Salts of volatile fatty acids.
21:6.0.1.1.23.2.2.61SECTION 573.920
     573.920 Selenium.
21:6.0.1.1.23.2.2.62SECTION 573.940
     573.940 Silicon dioxide.
21:6.0.1.1.23.2.2.63SECTION 573.960
     573.960 Sorbitan monostearate.
21:6.0.1.1.23.2.2.64SECTION 573.980
     573.980 Taurine.
21:6.0.1.1.23.2.2.65SECTION 573.1000
     573.1000 Verxite.
21:6.0.1.1.23.2.2.66SECTION 573.1010
     573.1010 Xanthan gum.
21:6.0.1.1.23.2.2.67SECTION 573.1020
     573.1020 Yellow prussiate of soda.
21:6.0.1.1.24PART 579
PART 579 - IRRADIATION IN THE PRODUCTION, PROCESSING, AND HANDLING OF ANIMAL FEED AND PET FOOD
21:6.0.1.1.24.1SUBPART A
Subpart A - General Provisions
21:6.0.1.1.24.1.2.1SECTION 579.12
     579.12 Incorporation of regulations in part 179.
21:6.0.1.1.24.2SUBPART B
Subpart B - Radiation and Radiation Sources
21:6.0.1.1.24.2.2.1SECTION 579.22
     579.22 Ionizing radiation for treatment of animal diets.
21:6.0.1.1.24.2.2.2SECTION 579.40
     579.40 Ionizing radiation for the treatment of poultry feed and poultry feed ingredients.
21:6.0.1.1.25PART 582
PART 582 - SUBSTANCES GENERALLY RECOGNIZED AS SAFE
21:6.0.1.1.25.1SUBPART A
Subpart A - General Provisions
21:6.0.1.1.25.1.2.1SECTION 582.1
     582.1 Substances that are generally recognized as safe.
21:6.0.1.1.25.1.2.2SECTION 582.10
     582.10 Spices and other natural seasonings and flavorings.
21:6.0.1.1.25.1.2.3SECTION 582.20
     582.20 Essential oils, oleoresins (solvent-free), and natural extractives (including distillates).
21:6.0.1.1.25.1.2.4SECTION 582.30
     582.30 Natural substances used in conjunction with spices and other natural seasonings and flavorings.
21:6.0.1.1.25.1.2.5SECTION 582.40
     582.40 Natural extractives (solvent-free) used in conjunction with spices, seasonings, and flavorings.
21:6.0.1.1.25.1.2.6SECTION 582.50
     582.50 Certain other spices, seasonings, essential oils, oleoresins, and natural extracts.
21:6.0.1.1.25.1.2.7SECTION 582.60
     582.60 Synthetic flavoring substances and adjuvants.
21:6.0.1.1.25.1.2.8SECTION 582.80
     582.80 Trace minerals added to animal feeds.
21:6.0.1.1.25.1.2.9SECTION 582.99
     582.99 Adjuvants for pesticide chemicals.
21:6.0.1.1.25.2SUBPART B
Subpart B - General Purpose Food Additives
21:6.0.1.1.25.2.2.1SECTION 582.1005
     582.1005 Acetic acid.
21:6.0.1.1.25.2.2.2SECTION 582.1009
     582.1009 Adipic acid.
21:6.0.1.1.25.2.2.3SECTION 582.1033
     582.1033 Citric acid.
21:6.0.1.1.25.2.2.4SECTION 582.1057
     582.1057 Hydrochloric acid.
21:6.0.1.1.25.2.2.5SECTION 582.1061
     582.1061 Lactic acid.
21:6.0.1.1.25.2.2.6SECTION 582.1069
     582.1069 Malic acid.
21:6.0.1.1.25.2.2.7SECTION 582.1073
     582.1073 Phosphoric acid.
21:6.0.1.1.25.2.2.8SECTION 582.1077
     582.1077 Potassium acid tartrate.
21:6.0.1.1.25.2.2.9SECTION 582.1087
     582.1087 Sodium acid pyrophosphate.
21:6.0.1.1.25.2.2.10SECTION 582.1091
     582.1091 Succinic acid.
21:6.0.1.1.25.2.2.11SECTION 582.1095
     582.1095 Sulfuric acid.
21:6.0.1.1.25.2.2.12SECTION 582.1099
     582.1099 Tartaric acid.
21:6.0.1.1.25.2.2.13SECTION 582.1125
     582.1125 Aluminum sulfate.
21:6.0.1.1.25.2.2.14SECTION 582.1127
     582.1127 Aluminum ammonium sulfate.
21:6.0.1.1.25.2.2.15SECTION 582.1129
     582.1129 Aluminum potassium sulfate.
21:6.0.1.1.25.2.2.16SECTION 582.1131
     582.1131 Aluminum sodium sulfate.
21:6.0.1.1.25.2.2.17SECTION 582.1135
     582.1135 Ammonium bicarbonate.
21:6.0.1.1.25.2.2.18SECTION 582.1137
     582.1137 Ammonium carbonate.
21:6.0.1.1.25.2.2.19SECTION 582.1139
     582.1139 Ammonium hydroxide.
21:6.0.1.1.25.2.2.20SECTION 582.1141
     582.1141 Ammonium phosphate.
21:6.0.1.1.25.2.2.21SECTION 582.1143
     582.1143 Ammonium sulfate.
21:6.0.1.1.25.2.2.22SECTION 582.1155
     582.1155 Bentonite.
21:6.0.1.1.25.2.2.23SECTION 582.1165
     582.1165 Butane.
21:6.0.1.1.25.2.2.24SECTION 582.1191
     582.1191 Calcium carbonate.
21:6.0.1.1.25.2.2.25SECTION 582.1193
     582.1193 Calcium chloride.
21:6.0.1.1.25.2.2.26SECTION 582.1195
     582.1195 Calcium citrate.
21:6.0.1.1.25.2.2.27SECTION 582.1199
     582.1199 Calcium gluconate.
21:6.0.1.1.25.2.2.28SECTION 582.1205
     582.1205 Calcium hydroxide.
21:6.0.1.1.25.2.2.29SECTION 582.1207
     582.1207 Calcium lactate.
21:6.0.1.1.25.2.2.30SECTION 582.1210
     582.1210 Calcium oxide.
21:6.0.1.1.25.2.2.31SECTION 582.1217
     582.1217 Calcium phosphate.
21:6.0.1.1.25.2.2.32SECTION 582.1235
     582.1235 Caramel.
21:6.0.1.1.25.2.2.33SECTION 582.1240
     582.1240 Carbon dioxide.
21:6.0.1.1.25.2.2.34SECTION 582.1275
     582.1275 Dextrans.
21:6.0.1.1.25.2.2.35SECTION 582.1320
     582.1320 Glycerin.
21:6.0.1.1.25.2.2.36SECTION 582.1324
     582.1324 Glyceryl monostearate.
21:6.0.1.1.25.2.2.37SECTION 582.1355
     582.1355 Helium.
21:6.0.1.1.25.2.2.38SECTION 582.1366
     582.1366 Hydrogen peroxide.
21:6.0.1.1.25.2.2.39SECTION 582.1400
     582.1400 Lecithin.
21:6.0.1.1.25.2.2.40SECTION 582.1425
     582.1425 Magnesium carbonate.
21:6.0.1.1.25.2.2.41SECTION 582.1428
     582.1428 Magnesium hydroxide.
21:6.0.1.1.25.2.2.42SECTION 582.1431
     582.1431 Magnesium oxide.
21:6.0.1.1.25.2.2.43SECTION 582.1480
     582.1480 Methylcellulose.
21:6.0.1.1.25.2.2.44SECTION 582.1500
     582.1500 Monoammonium glutamate.
21:6.0.1.1.25.2.2.45SECTION 582.1516
     582.1516 Monopotassium glutamate.
21:6.0.1.1.25.2.2.46SECTION 582.1540
     582.1540 Nitrogen.
21:6.0.1.1.25.2.2.47SECTION 582.1585
     582.1585 Papain.
21:6.0.1.1.25.2.2.48SECTION 582.1613
     582.1613 Potassium bicarbonate.
21:6.0.1.1.25.2.2.49SECTION 582.1619
     582.1619 Potassium carbonate.
21:6.0.1.1.25.2.2.50SECTION 582.1625
     582.1625 Potassium citrate.
21:6.0.1.1.25.2.2.51SECTION 582.1631
     582.1631 Potassium hydroxide.
21:6.0.1.1.25.2.2.52SECTION 582.1643
     582.1643 Potassium sulfate.
21:6.0.1.1.25.2.2.53SECTION 582.1655
     582.1655 Propane.
21:6.0.1.1.25.2.2.54SECTION 582.1666
     582.1666 Propylene glycol.
21:6.0.1.1.25.2.2.55SECTION 582.1685
     582.1685 Rennet.
21:6.0.1.1.25.2.2.56SECTION 582.1711
     582.1711 Silica aerogel.
21:6.0.1.1.25.2.2.57SECTION 582.1721
     582.1721 Sodium acetate.
21:6.0.1.1.25.2.2.58SECTION 582.1736
     582.1736 Sodium bicarbonate.
21:6.0.1.1.25.2.2.59SECTION 582.1742
     582.1742 Sodium carbonate.
21:6.0.1.1.25.2.2.60SECTION 582.1745
     582.1745 Sodium carboxymethylcellulose.
21:6.0.1.1.25.2.2.61SECTION 582.1748
     582.1748 Sodium caseinate.
21:6.0.1.1.25.2.2.62SECTION 582.1751
     582.1751 Sodium citrate.
21:6.0.1.1.25.2.2.63SECTION 582.1763
     582.1763 Sodium hydroxide.
21:6.0.1.1.25.2.2.64SECTION 582.1775
     582.1775 Sodium pectinate.
21:6.0.1.1.25.2.2.65SECTION 582.1778
     582.1778 Sodium phosphate.
21:6.0.1.1.25.2.2.66SECTION 582.1781
     582.1781 Sodium aluminum phosphate.
21:6.0.1.1.25.2.2.67SECTION 582.1792
     582.1792 Sodium sesquicarbonate.
21:6.0.1.1.25.2.2.68SECTION 582.1804
     582.1804 Sodium potassium tartrate.
21:6.0.1.1.25.2.2.69SECTION 582.1810
     582.1810 Sodium tripolyphosphate.
21:6.0.1.1.25.2.2.70SECTION 582.1901
     582.1901 Triacetin.
21:6.0.1.1.25.2.2.71SECTION 582.1973
     582.1973 Beeswax.
21:6.0.1.1.25.2.2.72SECTION 582.1975
     582.1975 Bleached beeswax.
21:6.0.1.1.25.2.2.73SECTION 582.1978
     582.1978 Carnauba wax.
21:6.0.1.1.25.3SUBPART C
Subpart C - Anticaking Agents
21:6.0.1.1.25.3.2.1SECTION 582.2122
     582.2122 Aluminum calcium silicate.
21:6.0.1.1.25.3.2.2SECTION 582.2227
     582.2227 Calcium silicate.
21:6.0.1.1.25.3.2.3SECTION 582.2437
     582.2437 Magnesium silicate.
21:6.0.1.1.25.3.2.4SECTION 582.2727
     582.2727 Sodium aluminosilicate.
21:6.0.1.1.25.3.2.5SECTION 582.2729
     582.2729 Hydrated sodium calcium aluminosilicate.
21:6.0.1.1.25.3.2.6SECTION 582.2906
     582.2906 Tricalcium silicate.
21:6.0.1.1.25.4SUBPART D
Subpart D - Chemical Preservatives
21:6.0.1.1.25.4.2.1SECTION 582.3013
     582.3013 Ascorbic acid.
21:6.0.1.1.25.4.2.2SECTION 582.3021
     582.3021 Benzoic acid.
21:6.0.1.1.25.4.2.3SECTION 582.3041
     582.3041 Erythorbic acid.
21:6.0.1.1.25.4.2.4SECTION 582.3081
     582.3081 Propionic acid.
21:6.0.1.1.25.4.2.5SECTION 582.3089
     582.3089 Sorbic acid.
21:6.0.1.1.25.4.2.6SECTION 582.3109
     582.3109 Thiodipropionic acid.
21:6.0.1.1.25.4.2.7SECTION 582.3149
     582.3149 Ascorbyl palmitate.
21:6.0.1.1.25.4.2.8SECTION 582.3169
     582.3169 Butylated hydroxyanisole.
21:6.0.1.1.25.4.2.9SECTION 582.3173
     582.3173 Butylated hydroxytoluene.
21:6.0.1.1.25.4.2.10SECTION 582.3189
     582.3189 Calcium ascorbate.
21:6.0.1.1.25.4.2.11SECTION 582.3221
     582.3221 Calcium propionate.
21:6.0.1.1.25.4.2.12SECTION 582.3225
     582.3225 Calcium sorbate.
21:6.0.1.1.25.4.2.13SECTION 582.3280
     582.3280 Dilauryl thiodipropionate.
21:6.0.1.1.25.4.2.14SECTION 582.3336
     582.3336 Gum guaiac.
21:6.0.1.1.25.4.2.15SECTION 582.3490
     582.3490 Methylparaben.
21:6.0.1.1.25.4.2.16SECTION 582.3616
     582.3616 Potassium bisulfite.
21:6.0.1.1.25.4.2.17SECTION 582.3637
     582.3637 Potassium metabisulfite.
21:6.0.1.1.25.4.2.18SECTION 582.3640
     582.3640 Potassium sorbate.
21:6.0.1.1.25.4.2.19SECTION 582.3660
     582.3660 Propyl gallate.
21:6.0.1.1.25.4.2.20SECTION 582.3670
     582.3670 Propylparaben.
21:6.0.1.1.25.4.2.21SECTION 582.3731
     582.3731 Sodium ascorbate.
21:6.0.1.1.25.4.2.22SECTION 582.3733
     582.3733 Sodium benzoate.
21:6.0.1.1.25.4.2.23SECTION 582.3739
     582.3739 Sodium bisulfite.
21:6.0.1.1.25.4.2.24SECTION 582.3766
     582.3766 Sodium metabisulfite.
21:6.0.1.1.25.4.2.25SECTION 582.3784
     582.3784 Sodium propionate.
21:6.0.1.1.25.4.2.26SECTION 582.3795
     582.3795 Sodium sorbate.
21:6.0.1.1.25.4.2.27SECTION 582.3798
     582.3798 Sodium sulfite.
21:6.0.1.1.25.4.2.28SECTION 582.3845
     582.3845 Stannous chloride.
21:6.0.1.1.25.4.2.29SECTION 582.3862
     582.3862 Sulfur dioxide.
21:6.0.1.1.25.4.2.30SECTION 582.3890
     582.3890 Tocopherols.
21:6.0.1.1.25.5SUBPART E
Subpart E - Emulsifying Agents
21:6.0.1.1.25.5.2.1SECTION 582.4101
     582.4101 Diacetyl tartaric acid esters of mono- and diglycerides of edible fats or oils, or edible fat-forming fatty acids.
21:6.0.1.1.25.5.2.2SECTION 582.4505
     582.4505 Mono- and diglycerides of edible fats or oils, or edible fat-forming acids.
21:6.0.1.1.25.5.2.3SECTION 582.4521
     582.4521 Monosodium phosphate derivatives of mono- and diglycerides of edible fats or oils, or edible fat-forming fatty acids.
21:6.0.1.1.25.5.2.4SECTION 582.4666
     582.4666 Propylene glycol.
21:6.0.1.1.25.6SUBPART F
Subpart F - Nutrients and/or Dietary Supplements 1
21:6.0.1.1.25.6.2.1SECTION 582.5013
     582.5013 Ascorbic acid.
21:6.0.1.1.25.6.2.2SECTION 582.5017
     582.5017 Aspartic acid.
21:6.0.1.1.25.6.2.3SECTION 582.5049
     582.5049 Aminoacetic acid.
21:6.0.1.1.25.6.2.4SECTION 582.5065
     582.5065 Linoleic acid.
21:6.0.1.1.25.6.2.5SECTION 582.5118
     582.5118 Alanine.
21:6.0.1.1.25.6.2.6SECTION 582.5145
     582.5145 Arginine.
21:6.0.1.1.25.6.2.7SECTION 582.5159
     582.5159 Biotin.
21:6.0.1.1.25.6.2.8SECTION 582.5191
     582.5191 Calcium carbonate.
21:6.0.1.1.25.6.2.9SECTION 582.5195
     582.5195 Calcium citrate.
21:6.0.1.1.25.6.2.10SECTION 582.5201
     582.5201 Calcium glycerophosphate.
21:6.0.1.1.25.6.2.11SECTION 582.5210
     582.5210 Calcium oxide.
21:6.0.1.1.25.6.2.12SECTION 582.5212
     582.5212 Calcium pantothenate.
21:6.0.1.1.25.6.2.13SECTION 582.5217
     582.5217 Calcium phosphate.
21:6.0.1.1.25.6.2.14SECTION 582.5223
     582.5223 Calcium pyrophosphate.
21:6.0.1.1.25.6.2.15SECTION 582.5230
     582.5230 Calcium sulfate.
21:6.0.1.1.25.6.2.16SECTION 582.5245
     582.5245 Carotene.
21:6.0.1.1.25.6.2.17SECTION 582.5250
     582.5250 Choline bitartrate.
21:6.0.1.1.25.6.2.18SECTION 582.5252
     582.5252 Choline chloride.
21:6.0.1.1.25.6.2.19SECTION 582.5260
     582.5260 Copper gluconate.
21:6.0.1.1.25.6.2.20SECTION 582.5271
     582.5271 Cysteine.
21:6.0.1.1.25.6.2.21SECTION 582.5273
     582.5273 Cystine.
21:6.0.1.1.25.6.2.22SECTION 582.5301
     582.5301 Ferric phosphate.
21:6.0.1.1.25.6.2.23SECTION 582.5304
     582.5304 Ferric pyrophosphate.
21:6.0.1.1.25.6.2.24SECTION 582.5306
     582.5306 Ferric sodium pyrophosphate.
21:6.0.1.1.25.6.2.25SECTION 582.5308
     582.5308 Ferrous gluconate.
21:6.0.1.1.25.6.2.26SECTION 582.5311
     582.5311 Ferrous lactate.
21:6.0.1.1.25.6.2.27SECTION 582.5315
     582.5315 Ferrous sulfate.
21:6.0.1.1.25.6.2.28SECTION 582.5361
     582.5361 Histidine.
21:6.0.1.1.25.6.2.29SECTION 582.5370
     582.5370 Inositol.
21:6.0.1.1.25.6.2.30SECTION 582.5375
     582.5375 Iron reduced.
21:6.0.1.1.25.6.2.31SECTION 582.5381
     582.5381 Isoleucine.
21:6.0.1.1.25.6.2.32SECTION 582.5406
     582.5406 Leucine.
21:6.0.1.1.25.6.2.33SECTION 582.5411
     582.5411 Lysine.
21:6.0.1.1.25.6.2.34SECTION 582.5431
     582.5431 Magnesium oxide.
21:6.0.1.1.25.6.2.35SECTION 582.5434
     582.5434 Magnesium phosphate.
21:6.0.1.1.25.6.2.36SECTION 582.5443
     582.5443 Magnesium sulfate.
21:6.0.1.1.25.6.2.37SECTION 582.5446
     582.5446 Manganese chloride.
21:6.0.1.1.25.6.2.38SECTION 582.5449
     582.5449 Manganese citrate.
21:6.0.1.1.25.6.2.39SECTION 582.5452
     582.5452 Manganese gluconate.
21:6.0.1.1.25.6.2.40SECTION 582.5455
     582.5455 Manganese glycerophosphate.
21:6.0.1.1.25.6.2.41SECTION 582.5458
     582.5458 Manganese hypophosphite.
21:6.0.1.1.25.6.2.42SECTION 582.5461
     582.5461 Manganese sulfate.
21:6.0.1.1.25.6.2.43SECTION 582.5464
     582.5464 Manganous oxide.
21:6.0.1.1.25.6.2.44SECTION 582.5470
     582.5470 Mannitol.
21:6.0.1.1.25.6.2.45SECTION 582.5475
     582.5475 Methionine.
21:6.0.1.1.25.6.2.46SECTION 582.5477
     582.5477 Methionine hydroxy analog and its calcium salts.
21:6.0.1.1.25.6.2.47SECTION 582.5530
     582.5530 Niacin.
21:6.0.1.1.25.6.2.48SECTION 582.5535
     582.5535 Niacinamide.
21:6.0.1.1.25.6.2.49SECTION 582.5580
     582.5580 D-Pantothenyl alcohol.
21:6.0.1.1.25.6.2.50SECTION 582.5590
     582.5590 Phenylalanine.
21:6.0.1.1.25.6.2.51SECTION 582.5622
     582.5622 Potassium chloride.
21:6.0.1.1.25.6.2.52SECTION 582.5628
     582.5628 Potassium glycerophosphate.
21:6.0.1.1.25.6.2.53SECTION 582.5634
     582.5634 Potassium iodide.
21:6.0.1.1.25.6.2.54SECTION 582.5650
     582.5650 Proline.
21:6.0.1.1.25.6.2.55SECTION 582.5676
     582.5676 Pyridoxine hydrochloride.
21:6.0.1.1.25.6.2.56SECTION 582.5695
     582.5695 Riboflavin.
21:6.0.1.1.25.6.2.57SECTION 582.5697
     582.5697 Riboflavin-5-phosphate.
21:6.0.1.1.25.6.2.58SECTION 582.5701
     582.5701 Serine.
21:6.0.1.1.25.6.2.59SECTION 582.5772
     582.5772 Sodium pantothenate.
21:6.0.1.1.25.6.2.60SECTION 582.5778
     582.5778 Sodium phosphate.
21:6.0.1.1.25.6.2.61SECTION 582.5835
     582.5835 Sorbitol.
21:6.0.1.1.25.6.2.62SECTION 582.5875
     582.5875 Thiamine hydrochloride.
21:6.0.1.1.25.6.2.63SECTION 582.5878
     582.5878 Thiamine mononitrate.
21:6.0.1.1.25.6.2.64SECTION 582.5881
     582.5881 Threonine.
21:6.0.1.1.25.6.2.65SECTION 582.5890
     582.5890 Tocopherols.
21:6.0.1.1.25.6.2.66SECTION 582.5892
     582.5892 a-Tocopherol acetate.
21:6.0.1.1.25.6.2.67SECTION 582.5915
     582.5915 Tryptophane.
21:6.0.1.1.25.6.2.68SECTION 582.5920
     582.5920 Tyrosine.
21:6.0.1.1.25.6.2.69SECTION 582.5925
     582.5925 Valine.
21:6.0.1.1.25.6.2.70SECTION 582.5930
     582.5930 Vitamin A.
21:6.0.1.1.25.6.2.71SECTION 582.5933
     582.5933 Vitamin A acetate.
21:6.0.1.1.25.6.2.72SECTION 582.5936
     582.5936 Vitamin A palmitate.
21:6.0.1.1.25.6.2.73SECTION 582.5945
     582.5945 Vitamin B2.
21:6.0.1.1.25.6.2.74SECTION 582.5950
     582.5950 Vitamin D2.
21:6.0.1.1.25.6.2.75SECTION 582.5953
     582.5953 Vitamin D2.
21:6.0.1.1.25.6.2.76SECTION 582.5985
     582.5985 Zinc chloride.
21:6.0.1.1.25.6.2.77SECTION 582.5988
     582.5988 Zinc gluconate.
21:6.0.1.1.25.6.2.78SECTION 582.5991
     582.5991 Zinc oxide.
21:6.0.1.1.25.6.2.79SECTION 582.5994
     582.5994 Zinc stearate.
21:6.0.1.1.25.6.2.80SECTION 582.5997
     582.5997 Zinc sulfate.
21:6.0.1.1.25.7SUBPART G
Subpart G - Sequestrants 2
21:6.0.1.1.25.7.2.1SECTION 582.6033
     582.6033 Citric acid.
21:6.0.1.1.25.7.2.2SECTION 582.6085
     582.6085 Sodium acid phosphate.
21:6.0.1.1.25.7.2.3SECTION 582.6099
     582.6099 Tartaric acid.
21:6.0.1.1.25.7.2.4SECTION 582.6185
     582.6185 Calcium acetate.
21:6.0.1.1.25.7.2.5SECTION 582.6193
     582.6193 Calcium chloride.
21:6.0.1.1.25.7.2.6SECTION 582.6195
     582.6195 Calcium citrate.
21:6.0.1.1.25.7.2.7SECTION 582.6197
     582.6197 Calcium diacetate.
21:6.0.1.1.25.7.2.8SECTION 582.6199
     582.6199 Calcium gluconate.
21:6.0.1.1.25.7.2.9SECTION 582.6203
     582.6203 Calcium hexametaphosphate.
21:6.0.1.1.25.7.2.10SECTION 582.6215
     582.6215 Monobasic calcium phosphate.
21:6.0.1.1.25.7.2.11SECTION 582.6219
     582.6219 Calcium phytate.
21:6.0.1.1.25.7.2.12SECTION 582.6285
     582.6285 Dipotassium phosphate.
21:6.0.1.1.25.7.2.13SECTION 582.6290
     582.6290 Disodium phosphate.
21:6.0.1.1.25.7.2.14SECTION 582.6386
     582.6386 Isopropyl citrate.
21:6.0.1.1.25.7.2.15SECTION 582.6511
     582.6511 Monoisopropyl citrate.
21:6.0.1.1.25.7.2.16SECTION 582.6625
     582.6625 Potassium citrate.
21:6.0.1.1.25.7.2.17SECTION 582.6751
     582.6751 Sodium citrate.
21:6.0.1.1.25.7.2.18SECTION 582.6754
     582.6754 Sodium diacetate.
21:6.0.1.1.25.7.2.19SECTION 582.6757
     582.6757 Sodium gluconate.
21:6.0.1.1.25.7.2.20SECTION 582.6760
     582.6760 Sodium hexametaphosphate.
21:6.0.1.1.25.7.2.21SECTION 582.6769
     582.6769 Sodium metaphosphate.
21:6.0.1.1.25.7.2.22SECTION 582.6778
     582.6778 Sodium phosphate.
21:6.0.1.1.25.7.2.23SECTION 582.6787
     582.6787 Sodium pyrophosphate.
21:6.0.1.1.25.7.2.24SECTION 582.6789
     582.6789 Tetra sodium pyrophosphate.
21:6.0.1.1.25.7.2.25SECTION 582.6801
     582.6801 Sodium tartrate.
21:6.0.1.1.25.7.2.26SECTION 582.6804
     582.6804 Sodium potassium tartrate.
21:6.0.1.1.25.7.2.27SECTION 582.6807
     582.6807 Sodium thiosulfate.
21:6.0.1.1.25.7.2.28SECTION 582.6810
     582.6810 Sodium tripolyphosphate.
21:6.0.1.1.25.7.2.29SECTION 582.6851
     582.6851 Stearyl citrate.
21:6.0.1.1.25.8SUBPART H
Subpart H - Stabilizers
21:6.0.1.1.25.8.2.1SECTION 582.7115
     582.7115 Agar-agar.
21:6.0.1.1.25.8.2.2SECTION 582.7133
     582.7133 Ammonium alginate.
21:6.0.1.1.25.8.2.3SECTION 582.7187
     582.7187 Calcium alginate.
21:6.0.1.1.25.8.2.4SECTION 582.7255
     582.7255 Chondrus extract.
21:6.0.1.1.25.8.2.5SECTION 582.7330
     582.7330 Gum arabic.
21:6.0.1.1.25.8.2.6SECTION 582.7333
     582.7333 Gum ghatti.
21:6.0.1.1.25.8.2.7SECTION 582.7339
     582.7339 Guar gum.
21:6.0.1.1.25.8.2.8SECTION 582.7343
     582.7343 Locust bean gum.
21:6.0.1.1.25.8.2.9SECTION 582.7349
     582.7349 Sterculia gum.
21:6.0.1.1.25.8.2.10SECTION 582.7351
     582.7351 Gum tragacanth.
21:6.0.1.1.25.8.2.11SECTION 582.7610
     582.7610 Potassium alginate.
21:6.0.1.1.25.8.2.12SECTION 582.7724
     582.7724 Sodium alginate.
21:6.0.1.1.26PART 584
PART 584 - FOOD SUBSTANCES AFFIRMED AS GENERALLY RECOGNIZED AS SAFE IN FEED AND DRINKING WATER OF ANIMALS
21:6.0.1.1.26.1SUBPART A
Subpart A [Reserved]
21:6.0.1.1.26.2SUBPART B
Subpart B - Listing of Specific Substances Affirmed as GRAS
21:6.0.1.1.26.2.2.1SECTION 584.200
     584.200 Ethyl alcohol containing ethyl acetate.
21:6.0.1.1.26.2.2.2SECTION 584.700
     584.700 Hydrophobic silicas.
21:6.0.1.1.26.2.2.3SECTION 584.725
     584.725 25-Hydroxyvitamin D3.
21:6.0.1.1.27PART 589
PART 589 - SUBSTANCES PROHIBITED FROM USE IN ANIMAL FOOD OR FEED
21:6.0.1.1.27.1SUBPART A
Subpart A - General Provisions
21:6.0.1.1.27.1.2.1SECTION 589.1
     589.1 Substances prohibited from use in animal food or feed.
21:6.0.1.1.27.2SUBPART B
Subpart B - Listing of Specific Substances Prohibited From Use in Animal Food or Feed
21:6.0.1.1.27.2.2.1SECTION 589.1000
     589.1000 Gentian violet.
21:6.0.1.1.27.2.2.2SECTION 589.1001
     589.1001 Propylene glycol in or on cat food.
21:6.0.1.1.27.2.2.3SECTION 589.2000
     589.2000 Animal proteins prohibited in ruminant feed.
21:6.0.1.1.27.2.2.4SECTION 589.2001
     589.2001 Cattle materials prohibited in animal food or feed to prevent the transmission of bovine spongiform encephalopathy.
21:6.0.1.1.28PART 590-599
PARTS 590-599 [RESERVED]